☰

Michael Green, PhD - Publications

Affiliations: 
University of Cambridge University of Cambridge, Cambridge, England, United Kingdom 
Area:
String Theory
Website:
http://en.wikipedia.org/wiki/Michael_Green_(physicist)
Tree Info Similar researchers PubMed Report error

2/500 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Mackie SL, Taylor JC, Haroon-Rashid L, Martin S, Dasgupta B, Gough A, Green M, Hordon L, Jarrett S, Pease CT, Barrett JH, Watts R, Morgan AW. Association of HLA-DRB1 amino acid residues with giant cell arteritis: genetic association study, meta-analysis and geo-epidemiological investigation. Arthritis Research & Therapy. 17: 195. PMID 26223536 DOI: 10.1186/S13075-015-0692-4  0.402
2015 Carmona FD, Mackie SL, Martín JE, Taylor JC, Vaglio A, Eyre S, Bossini-Castillo L, Castañeda S, Cid MC, Hernández-Rodríguez J, Prieto-González S, Solans R, Ramentol-Sintas M, González-Escribano MF, Ortiz-Fernández L, ... ... Green M, et al. A large-scale genetic analysis reveals a strong contribution of the HLA class II region to giant cell arteritis susceptibility. American Journal of Human Genetics. 96: 565-80. PMID 25817017 DOI: 10.1016/J.Ajhg.2015.02.009  0.403
Low-probability matches (unlikely to be authored by this person)
2024 Jiang CY, Zhao L, Green MD, Ravishankar S, Towlerton AMH, Scott AJ, Raghavan M, Cusick MF, Warren EH, Ramnath N. Class II HLA-DRB4 is a predictive biomarker for survival following immunotherapy in metastatic non-small cell lung cancer. Scientific Reports. 14: 345. PMID 38172168 DOI: 10.1038/s41598-023-48546-y  0.256
1999 Quarmby IC, Hemond RC, Feher FJ, Green M, Geiger WE. Redox properties of the 17-electron sandwich (η5-C5H5)Mo(η6-C6Ph6): electrochemical characterization of the 16 e− Lewis acid monocation and its PF6− adduct Journal of Organometallic Chemistry. 577: 189-196. DOI: 10.1016/S0022-328X(98)01038-9  0.198
2005 Green MF, Barnes TR, Danion JM, Gallhofer B, Meltzer HY, Pantelis C. The FOCIS international survey on psychiatrists' opinions on cognition in schizophrenia. Schizophrenia Research. 74: 253-61. PMID 15722004 DOI: 10.1016/J.Schres.2004.05.023  0.197
2014 Felice Reddy L, Green MF, Rizzo S, Sugar CA, Blanchard JJ, Gur RE, Kring AM, Horan WP. Behavioral approach and avoidance in schizophrenia: an evaluation of motivational profiles. Schizophrenia Research. 159: 164-70. PMID 25153364 DOI: 10.1016/J.Schres.2014.07.047  0.197
2018 Rassovsky Y, Dunn W, Wynn JK, Wu AD, Iacoboni M, Hellemann G, Green MF. Single transcranial direct current stimulation in schizophrenia: Randomized, cross-over study of neurocognition, social cognition, ERPs, and side effects. Plos One. 13: e0197023. PMID 29734347 DOI: 10.1371/Journal.Pone.0197023  0.196
2016 Green MF. Impact of cognitive and social cognitive impairment on functional outcomes in patients with schizophrenia. The Journal of Clinical Psychiatry. 77: 8-11. PMID 26919052 DOI: 10.4088/Jcp.14074Su1C.02  0.196
2012 Harvey PD, Heaton RK, Carpenter WT, Green MF, Gold JM, Schoenbaum M. Functional impairment in people with schizophrenia: focus on employability and eligibility for disability compensation. Schizophrenia Research. 140: 1-8. PMID 22503642 DOI: 10.1016/J.Schres.2012.03.025  0.196
2000 Green M. Strings draw theorists together Physics World. 13: 21-22. DOI: 10.1088/2058-7058/13/3/23  0.196
2011 Nuechterlein KH, Subotnik KL, Green MF, Ventura J, Asarnow RF, Gitlin MJ, Yee CM, Gretchen-Doorly D, Mintz J. Neurocognitive predictors of work outcome in recent-onset schizophrenia. Schizophrenia Bulletin. 37: S33-40. PMID 21860045 DOI: 10.1093/Schbul/Sbr084  0.196
2019 Cooper JA, Barch DM, Reddy LF, Horan WP, Green MF, Treadway MT. Effortful goal-directed behavior in schizophrenia: Computational subtypes and associations with cognition. Journal of Abnormal Psychology. PMID 31282687 DOI: 10.1037/Abn0000443  0.195
2004 Flashman LA, Green MF. Review of cognition and brain structure in schizophrenia: profiles, longitudinal course, and effects of treatment. The Psychiatric Clinics of North America. 27: 1-18, vii. PMID 15062627 DOI: 10.1016/S0193-953X(03)00105-9  0.194
2004 Kee KS, Horan WP, Mintz J, Green MF. Do the siblings of schizophrenia patients demonstrate affect perception deficits? Schizophrenia Research. 67: 87-94. PMID 14741328 DOI: 10.1016/S0920-9964(03)00217-2  0.194
2013 Lane HY, Lin CH, Green MF, Hellemann G, Huang CC, Chen PW, Tun R, Chang YC, Tsai GE. Add-on treatment of benzoate for schizophrenia: a randomized, double-blind, placebo-controlled trial of D-amino acid oxidase inhibitor. Jama Psychiatry. 70: 1267-75. PMID 24089054 DOI: 10.1001/Jamapsychiatry.2013.2159  0.194
2004 Harvey PD, Green MF, Keefe RS, Velligan DI. Cognitive functioning in schizophrenia: a consensus statement on its role in the definition and evaluation of effective treatments for the illness. The Journal of Clinical Psychiatry. 65: 361-72. PMID 15096076 DOI: 10.4088/Jcp.V65N0312  0.194
2020 Bezdicek O, Michalec J, Kališová L, Kufa T, Děchtěrenko F, Chlebovcová M, Havlík F, Green MF, Nuechterlein KH. Profile of cognitive deficits in schizophrenia and factor structure of the Czech MATRICS Consensus Cognitive Battery. Schizophrenia Research. PMID 32089475 DOI: 10.1016/J.Schres.2020.02.004  0.192
2015 Reddy LF, Horan WP, Barch DM, Buchanan RW, Dunayevich E, Gold JM, Lyons N, Marder SR, Treadway MT, Wynn JK, Young JW, Green MF. Effort-Based Decision-Making Paradigms for Clinical Trials in Schizophrenia: Part 1-Psychometric Characteristics of 5 Paradigms. Schizophrenia Bulletin. PMID 26142081 DOI: 10.1093/Schbul/Sbv089  0.192
2015 Matosin N, Green MJ, Andrews JL, Newell KA, Fernandez-Enright F. Possibility of a sex-specific role for a genetic variant in FRMPD4 in schizophrenia, but not cognitive function. Neuroreport. PMID 26555035 DOI: 10.1097/WNR.0000000000000491  0.191
2001 Green MF, Braff DL. Translating the basic and clinical cognitive neuroscience of schizophrenia to drug development and clinical trials of antipsychotic medications. Biological Psychiatry. 49: 374-84. PMID 11239909 DOI: 10.1016/S0006-3223(00)01027-1  0.191
2010 Horan WP, Rassovsky Y, Kern RS, Lee J, Wynn JK, Green MF. Further support for the role of dysfunctional attitudes in models of real-world functioning in schizophrenia. Journal of Psychiatric Research. 44: 499-505. PMID 20006849 DOI: 10.1016/J.Jpsychires.2009.11.001  0.191
2013 Green MF, Horan WP, Sugar CA. Has the generalized deficit become the generalized criticism? Schizophrenia Bulletin. 39: 257-62. PMID 23236079 DOI: 10.1093/Schbul/Sbs146  0.191
2014 Horan WP, Pineda JA, Wynn JK, Iacoboni M, Green MF. Some markers of mirroring appear intact in schizophrenia: evidence from mu suppression. Cognitive, Affective & Behavioral Neuroscience. 14: 1049-60. PMID 24415272 DOI: 10.3758/S13415-013-0245-8  0.191
2012 Nuechterlein KH, Subotnik KL, Ventura J, Green MF, Gretchen-Doorly D, Asarnow RF. The puzzle of schizophrenia: tracking the core role of cognitive deficits. Development and Psychopathology. 24: 529-36. PMID 22559128 DOI: 10.1017/S0954579412000132  0.19
1999 Green MF, Nuechterlein KH. Backward masking performance as an indicator of vulnerability to schizophrenia. Acta Psychiatrica Scandinavica. Supplementum. 395: 34-40. PMID 10225331 DOI: 10.1111/J.1600-0447.1999.Tb05981.X  0.19
2009 Vaskinn A, Sergi MJ, Green MF. The challenges of ecological validity in the measurement of social perception in schizophrenia. The Journal of Nervous and Mental Disease. 197: 700-2. PMID 19752651 DOI: 10.1097/Nmd.0B013E3181B3Ae62  0.19
2009 Sergi MJ, Fiske AP, Horan WP, Kern RS, Kee KS, Subotnik KL, Nuechterlein KH, Green MF. Development of a measure of relationship perception in schizophrenia. Psychiatry Research. 166: 54-62. PMID 19193447 DOI: 10.1016/J.Psychres.2008.03.010  0.189
2009 Kern RS, Green MF, Fiske AP, Kee KS, Lee J, Sergi MJ, Horan WP, Subotnik KL, Sugar CA, Nuechterlein KH. Theory of mind deficits for processing counterfactual information in persons with chronic schizophrenia. Psychological Medicine. 39: 645-54. PMID 18694537 DOI: 10.1017/S0033291708003966  0.188
1964 Green M, Linnett JW. Hydrogen peroxide in the slow thermal reaction of hydrogen and oxygen [7] Nature. 202: 80. DOI: 10.1038/202080A0  0.187
1999 Green MF, Nuechterlein KH. Should schizophrenia be treated as a neurocognitive disorder? Schizophrenia Bulletin. 25: 309-19. PMID 10416733 DOI: 10.1093/Oxfordjournals.Schbul.A033380  0.186
2010 Wynn JK, Sugar C, Horan WP, Kern R, Green MF. Mismatch negativity, social cognition, and functioning in schizophrenia patients. Biological Psychiatry. 67: 940-7. PMID 20074704 DOI: 10.1016/J.Biopsych.2009.11.024  0.186
2008 Horan WP, Braff DL, Nuechterlein KH, Sugar CA, Cadenhead KS, Calkins ME, Dobie DJ, Freedman R, Greenwood TA, Gur RE, Gur RC, Light GA, Mintz J, Olincy A, Radant AD, ... ... Green MF, et al. Verbal working memory impairments in individuals with schizophrenia and their first-degree relatives: findings from the Consortium on the Genetics of Schizophrenia. Schizophrenia Research. 103: 218-28. PMID 18406578 DOI: 10.1016/J.Schres.2008.02.014  0.186
2012 Horan WP, Foti D, Hajcak G, Wynn JK, Green MF. Impaired neural response to internal but not external feedback in schizophrenia. Psychological Medicine. 42: 1637-47. PMID 22152069 DOI: 10.1017/S0033291711002819  0.185
2004 Green MF, Nuechterlein KH. The MATRICS initiative: developing a consensus cognitive battery for clinical trials. Schizophrenia Research. 72: 1-3. PMID 15531401 DOI: 10.1016/J.Schres.2004.09.006  0.185
2015 Radant AD, Millard SP, Braff DL, Calkins ME, Dobie DJ, Freedman R, Green MF, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Light GA, Meichle SP, Nuechterlein KH, Olincy A, et al. Robust differences in antisaccade performance exist between COGS schizophrenia cases and controls regardless of recruitment strategies. Schizophrenia Research. 163: 47-52. PMID 25553977 DOI: 10.1016/J.Schres.2014.12.016  0.185
2005 Horan WP, Rassovsky Y, Green MF. Stimulating development of new drugs to improve cognition in schizophrenia Current Psychosis & Therapeutics Reports. 3: 68-73. DOI: 10.1007/Bf02629424  0.185
2013 Lee J, Altshuler L, Glahn DC, Miklowitz DJ, Ochsner K, Green MF. Social and nonsocial cognition in bipolar disorder and schizophrenia: relative levels of impairment. The American Journal of Psychiatry. 170: 334-41. PMID 23450289 DOI: 10.1176/Appi.Ajp.2012.12040490  0.185
2003 Sergi MJ, Green MF. Social perception and early visual processing in schizophrenia. Schizophrenia Research. 59: 233-41. PMID 12414080 DOI: 10.1016/S0920-9964(01)00405-4  0.185
2014 Green MF, Harvey PD. Cognition in schizophrenia: Past, present, and future. Schizophrenia Research. Cognition. 1: e1-e9. PMID 25254156 DOI: 10.1016/J.Scog.2014.02.001  0.185
2004 Wynn JK, Dawson ME, Schell AM, McGee M, Salveson D, Green MF. Prepulse facilitation and prepulse inhibition in schizophrenia patients and their unaffected siblings. Biological Psychiatry. 55: 518-23. PMID 15023580 DOI: 10.1016/J.Biopsych.2003.10.018  0.185
2006 Green M. String theory: On the shoulders of giants Nature Physics. 2: 73-74. DOI: 10.1038/Nphys220  0.185
2013 Green MF. Commentary on "Cognition in schizophrenia". European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 23: 786-7. PMID 23676292 DOI: 10.1016/J.Euroneuro.2013.04.008  0.184
2007 Green MF. Stimulating the development of drug treatments to improve cognition in schizophrenia. Annual Review of Clinical Psychology. 3: 159-80. PMID 17716052 DOI: 10.1146/Annurev.Clinpsy.3.022806.091529  0.183
2016 Millard SP, Shofer J, Braff D, Calkins M, Cadenhead K, Freedman R, Green MF, Greenwood TA, Gur R, Gur R, Lazzeroni LC, Light GA, Olincy A, Nuechterlein K, Seidman L, et al. Prioritizing schizophrenia endophenotypes for future genetic studies: An example using data from the COGS-1 family study. Schizophrenia Research. PMID 27132484 DOI: 10.1016/J.Schres.2016.04.011  0.183
2006 Glahn DC, Barrett J, Bearden CE, Mintz J, Green MF, Serap Monkul E, Najt P, Soares JC, Velligan DI. Dissociable mechanisms for memory impairment in bipolar disorder and schizophrenia. Psychological Medicine. 36: 1085-95. PMID 16734948 DOI: 10.1017/S0033291706007902  0.183
2013 Lee J, Kern RS, Harvey PO, Horan WP, Kee KS, Ochsner K, Penn DL, Green MF. An intact social cognitive process in schizophrenia: situational context effects on perception of facial affect. Schizophrenia Bulletin. 39: 640-7. PMID 22532704 DOI: 10.1093/Schbul/Sbs063  0.182
2011 Lee J, Quintana J, Nori P, Green MF. Theory of mind in schizophrenia: exploring neural mechanisms of belief attribution. Social Neuroscience. 6: 569-81. PMID 22050432 DOI: 10.1080/17470919.2011.620774  0.18
2015 Rose A, Vinogradov S, Fisher M, Green MF, Ventura J, Hooker C, Merzenich M, Nahum M. Randomized controlled trial of computer-based treatment of social cognition in schizophrenia: the TRuSST trial protocol. Bmc Psychiatry. 15: 142. PMID 26138715 DOI: 10.1186/S12888-015-0510-1  0.18
2008 Lee J, Nuechterlein KH, Subotnik KL, Sugar CA, Ventura J, Gretchen-Doorly D, Kelly K, Green MF. Stability of visual masking performance in recent-onset schizophrenia: an 18-month longitudinal study. Schizophrenia Research. 103: 266-74. PMID 18450427 DOI: 10.1016/J.Schres.2008.03.005  0.18
2015 J?drasik-Sty?a M, Cio?kiewicz A, Sty?a R, Linke M, Parnowska D, Gruszka A, Denisiuk M, Jarema M, Green MF, Wichniak A. The Polish Academic Version of the MATRICS Consensus Cognitive Battery (MCCB): Evaluation of Psychometric Properties. The Psychiatric Quarterly. PMID 25601030 DOI: 10.1007/S11126-015-9343-9  0.18
2016 Yang YS, Marder SR, Green MF. Repurposing Drugs for Cognition in Schizophrenia. Clinical Pharmacology and Therapeutics. PMID 27706797 DOI: 10.1002/Cpt.529  0.179
2013 Green MF, Lee J, Ochsner KN. Adapting social neuroscience measures for schizophrenia clinical trials, Part 1: ferrying paradigms across perilous waters. Schizophrenia Bulletin. 39: 1192-200. PMID 24072811 DOI: 10.1093/Schbul/Sbt131  0.179
1999 Satz P, Green MF. Atypical handedness in schizophrenia: some methodological and theoretical issues. Schizophrenia Bulletin. 25: 63-78. PMID 10098914 DOI: 10.1093/Oxfordjournals.Schbul.A033367  0.179
2008 Horan WP, Blanchard JJ, Clark LA, Green MF. Affective traits in schizophrenia and schizotypy. Schizophrenia Bulletin. 34: 856-74. PMID 18667393 DOI: 10.1093/Schbul/Sbn083  0.179
2014 Davis MC, Horan WP, Nurmi EL, Rizzo S, Li W, Sugar CA, Green MF. Associations between oxytocin receptor genotypes and social cognitive performance in individuals with schizophrenia. Schizophrenia Research. 159: 353-7. PMID 25244972 DOI: 10.1016/J.Schres.2014.09.006  0.178
2011 Buchanan RW, Keefe RS, Umbricht D, Green MF, Laughren T, Marder SR. The FDA-NIMH-MATRICS guidelines for clinical trial design of cognitive-enhancing drugs: what do we know 5 years later? Schizophrenia Bulletin. 37: 1209-17. PMID 20410237 DOI: 10.1093/Schbul/Sbq038  0.178
2003 Keefe RS, Mohs RC, Bilder RM, Harvey PD, Green MF, Meltzer HY, Gold JM, Sano M. Neurocognitive assessment in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project schizophrenia trial: development, methodology, and rationale. Schizophrenia Bulletin. 29: 45-55. PMID 12908660 DOI: 10.1093/Oxfordjournals.Schbul.A006990  0.178
2020 Nahum M, Lee H, Fisher M, Green MF, Hooker CI, Ventura J, Jordan JT, Rose A, Kim SJ, Haut KM, Merzenich MM, Vinogradov S. Online Social Cognition Training in Schizophrenia: A Double-Blind, Randomized, Controlled Multi-Site Clinical Trial. Schizophrenia Bulletin. PMID 32614046 DOI: 10.1093/Schbul/Sbaa085  0.178
2011 Kern RS, Gold JM, Dickinson D, Green MF, Nuechterlein KH, Baade LE, Keefe RS, Mesholam-Gately RI, Seidman LJ, Lee C, Sugar CA, Marder SR. The MCCB impairment profile for schizophrenia outpatients: results from the MATRICS psychometric and standardization study. Schizophrenia Research. 126: 124-31. PMID 21159492 DOI: 10.1016/J.Schres.2010.11.008  0.178
2007 Wynn JK, Green MF, Sprock J, Light GA, Widmark C, Reist C, Erhart S, Marder SR, Mintz J, Braff DL. Effects of olanzapine, risperidone and haloperidol on prepulse inhibition in schizophrenia patients: a double-blind, randomized controlled trial. Schizophrenia Research. 95: 134-42. PMID 17662577 DOI: 10.1016/J.Schres.2007.05.039  0.177
2017 Kilian S, Asmal L, Chiliza B, Olivier MR, Phahladira L, Scheffler F, Seedat S, Marder SR, Green MF, Emsley R. Childhood adversity and cognitive function in schizophrenia spectrum disorders and healthy controls: evidence for an association between neglect and social cognition. Psychological Medicine. 1-8. PMID 29268811 DOI: 10.1017/S0033291717003671  0.177
2011 Greenwood TA, Lazzeroni LC, Murray SS, Cadenhead KS, Calkins ME, Dobie DJ, Green MF, Gur RE, Gur RC, Hardiman G, Kelsoe JR, Leonard S, Light GA, Nuechterlein KH, Olincy A, et al. Analysis of 94 candidate genes and 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia. The American Journal of Psychiatry. 168: 930-46. PMID 21498463 DOI: 10.1176/Appi.Ajp.2011.10050723  0.177
2013 Kern RS, Penn DL, Lee J, Horan WP, Reise SP, Ochsner KN, Marder SR, Green MF. Adapting social neuroscience measures for schizophrenia clinical trials, Part 2: trolling the depths of psychometric properties. Schizophrenia Bulletin. 39: 1201-10. PMID 24072805 DOI: 10.1093/Schbul/Sbt127  0.176
2016 Thomas ML, Green MF, Hellemann G, Sugar CA, Tarasenko M, Calkins ME, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Nuechterlein KH, Radant AD, Seidman LJ, Shiluk AL, Siever LJ, et al. Modeling Deficits From Early Auditory Information Processing to Psychosocial Functioning in Schizophrenia. Jama Psychiatry. PMID 27926742 DOI: 10.1001/Jamapsychiatry.2016.2980  0.176
2019 Green MF, Horan WP, Lee J. Nonsocial and social cognition in schizophrenia: current evidence and future directions. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 18: 146-161. PMID 31059632 DOI: 10.1002/Wps.20624  0.176
2004 Ventura J, Nuechterlein KH, Subotnik KL, Green MF, Gitlin MJ. Self-efficacy and neurocognition may be related to coping responses in recent-onset schizophrenia. Schizophrenia Research. 69: 343-52. PMID 15469206 DOI: 10.1016/J.Schres.2003.09.002  0.175
2012 Harvey PD, Heaton RK, Carpenter WT, Green MF, Gold JM, Schoenbaum M. Diagnosis of schizophrenia: consistency across information sources and stability of the condition. Schizophrenia Research. 140: 9-14. PMID 22503641 DOI: 10.1016/J.Schres.2012.03.026  0.175
2014 Tsuang D, Esterberg M, Braff D, Calkins M, Cadenhead K, Dobie D, Freedman R, Green MF, Greenwood T, Gur R, Gur R, Horan W, Lazzeroni LC, Light GA, Millard SP, et al. Is there an association between advanced paternal age and endophenotype deficit levels in schizophrenia? Plos One. 9: e88379. PMID 24523888 DOI: 10.1371/Journal.Pone.0088379  0.175
1994 Green MF, Satz P, Christenson C. Minor physical anomalies in schizophrenia patients, bipolar patients, and their siblings. Schizophrenia Bulletin. 20: 433-40. PMID 7973464 DOI: 10.1093/Schbul/20.3.433  0.175
2002 Toomey R, Schuldberg D, Corrigan P, Green MF. Nonverbal social perception and symptomatology in schizophrenia. Schizophrenia Research. 53: 83-91. PMID 11728841 DOI: 10.1016/S0920-9964(01)00177-3  0.174
2019 Clayson PE, Wynn JK, Infantolino ZP, Hajcak G, Green MF, Horan WP. Reward processing in certain versus uncertain contexts in schizophrenia: An event-related potential (ERP) study. Journal of Abnormal Psychology. 128: 867-880. PMID 31657597 DOI: 10.1037/Abn0000469  0.174
2008 Green MF, Leitman DI. Social cognition in schizophrenia. Schizophrenia Bulletin. 34: 670-2. PMID 18495642 DOI: 10.1177/0963721410377600  0.174
2011 Green MF, Schooler NR, Kern RS, Frese FJ, Granberry W, Harvey PD, Karson CN, Peters N, Stewart M, Seidman LJ, Sonnenberg J, Stone WS, Walling D, Stover E, Marder SR. Evaluation of functionally meaningful measures for clinical trials of cognition enhancement in schizophrenia. The American Journal of Psychiatry. 168: 400-7. PMID 21285142 DOI: 10.1176/Appi.Ajp.2010.10030414  0.174
2015 Tabak NT, Green MF, Wynn JK, Proudfit GH, Altshuler L, Horan WP. Perceived emotional intelligence is impaired and associated with poor community functioning in schizophrenia and bipolar disorder. Schizophrenia Research. 162: 189-95. PMID 25579055 DOI: 10.1016/J.Schres.2014.12.005  0.174
1992 Corrigan PW, Wallace CJ, Green MF. Deficits in social schemata in schizophrenia. Schizophrenia Research. 8: 129-35. PMID 1457391 DOI: 10.1016/0920-9964(92)90029-5  0.174
2007 Calkins ME, Dobie DJ, Cadenhead KS, Olincy A, Freedman R, Green MF, Greenwood TA, Gur RE, Gur RC, Light GA, Mintz J, Nuechterlein KH, Radant AD, Schork NJ, Seidman LJ, et al. The Consortium on the Genetics of Endophenotypes in Schizophrenia: model recruitment, assessment, and endophenotyping methods for a multisite collaboration. Schizophrenia Bulletin. 33: 33-48. PMID 17035358 DOI: 10.1093/Schbul/Sbl044  0.173
2005 Green MF, Olivier B, Crawley JN, Penn DL, Silverstein S. Social cognition in schizophrenia: recommendations from the measurement and treatment research to improve cognition in schizophrenia new approaches conference. Schizophrenia Bulletin. 31: 882-7. PMID 16135561 DOI: 10.1093/Schbul/Sbi049  0.173
2013 Green MF, Penn DL. Going from social neuroscience to schizophrenia clinical trials. Schizophrenia Bulletin. 39: 1189-91. PMID 24072810 DOI: 10.1093/Schbul/Sbt128  0.173
1997 Mcgurk SR, Green MF, Wirshing WC, Ames D, Marshall B, Marder SR, Mintz J. The Effects of Risperidone vs Haloperidol on Cognitive Functioning in Treatment-Resistant Schizophrenia: The Trail Making Test Cns Spectrums. 2: 60-64. DOI: 10.1017/S1092852900005058  0.173
1992 Green MF. Neuropsychological performance in the unaffected twin. Archives of General Psychiatry. 49: 247. PMID 1567280 DOI: 10.1001/Archpsyc.1992.01820030079012  0.173
2008 Wynn JK, Green MF, Engel S, Korb A, Lee J, Glahn D, Nuechterlein KH, Cohen MS. Increased extent of object-selective cortex in schizophrenia. Psychiatry Research. 164: 97-105. PMID 18938066 DOI: 10.1016/J.Pscychresns.2008.01.005  0.173
2005 Rassovsky Y, Green MF, Nuechterlein KH, Breitmeyer B, Mintz J. Modulation of attention during visual masking in schizophrenia. The American Journal of Psychiatry. 162: 1533-5. PMID 16055778 DOI: 10.1176/Appi.Ajp.162.8.1533  0.173
2006 Harvey PD, Green MF, Bowie C, Loebel A. The dimensions of clinical and cognitive change in schizophrenia: evidence for independence of improvements. Psychopharmacology. 187: 356-63. PMID 16783539 DOI: 10.1007/S00213-006-0432-1  0.173
1999 Green MF, Nuechterlein KH, Breitmeyer B, Mintz J. Backward masking in unmedicated schizophrenic patients in psychotic remission: possible reflection of aberrant cortical oscillation. The American Journal of Psychiatry. 156: 1367-73. PMID 10484946 DOI: 10.1176/Ajp.156.9.1367  0.173
2020 Lee J, Green MF, Nuechterlein KH, Swerdlow NR, Greenwood TA, Hellemann GS, Lazzeroni LC, Light GA, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Sprock J, Stone WS, Sugar CA, et al. The effects of age and sex on cognitive impairment in schizophrenia: Findings from the Consortium on the Genetics of Schizophrenia (COGS) study. Plos One. 15: e0232855. PMID 32401791 DOI: 10.1371/Journal.Pone.0232855  0.172
2006 Wynn JK, Breitmeyer B, Nuechterlein KH, Green MF. Exploring the short term visual store in schizophrenia using the attentional blink. Journal of Psychiatric Research. 40: 599-605. PMID 16890242 DOI: 10.1016/J.Jpsychires.2006.06.002  0.172
2008 Goff DC, Lamberti JS, Leon AC, Green MF, Miller AL, Patel J, Manschreck T, Freudenreich O, Johnson SA. A placebo-controlled add-on trial of the Ampakine, CX516, for cognitive deficits in schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 33: 465-72. PMID 17487227 DOI: 10.1038/Sj.Npp.1301444  0.172
2012 Mathis KI, Wynn JK, Jahshan C, Hellemann G, Darque A, Green MF. An electrophysiological investigation of attentional blink in schizophrenia: separating perceptual and attentional processes. International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology. 86: 108-13. PMID 22771850 DOI: 10.1016/J.Ijpsycho.2012.06.052  0.172
2014 Nahum M, Fisher M, Loewy R, Poelke G, Ventura J, Nuechterlein KH, Hooker CI, Green MF, Merzenich M, Vinogradov S. A novel, online social cognitive training program for young adults with schizophrenia: A pilot study. Schizophrenia Research. Cognition. 1: e11-e19. PMID 25267937 DOI: 10.1016/J.Scog.2014.01.003  0.171
2014 Lee J, Cohen MS, Engel SA, Glahn D, Nuechterlein KH, Wynn JK, Green MF. Neural substrates of visual masking by object substitution in schizophrenia. Human Brain Mapping. 35: 4654-62. PMID 24677632 DOI: 10.1002/Hbm.22501  0.171
2015 Green MJ, Raudino A, Cairns MJ, Wu J, Tooney PA, Scott RJ, Carr VJ. Do common genotypes of FK506 binding protein 5 (FKBP5) moderate the effects of childhood maltreatment on cognition in schizophrenia and healthy controls? Journal of Psychiatric Research. 70: 9-17. PMID 26424418 DOI: 10.1016/j.jpsychires.2015.07.019  0.17
2019 Greenwood TA, Lazzeroni LC, Maihofer AX, Swerdlow NR, Calkins ME, Freedman R, Green MF, Light GA, Nievergelt CM, Nuechterlein KH, Radant AD, Siever LJ, Silverman JM, Stone WS, Sugar CA, et al. Genome-wide Association of Endophenotypes for Schizophrenia From the Consortium on the Genetics of Schizophrenia (COGS) Study. Jama Psychiatry. PMID 31596458 DOI: 10.1001/Jamapsychiatry.2019.2850  0.17
2008 Green MF, Penn DL, Bentall R, Carpenter WT, Gaebel W, Gur RC, Kring AM, Park S, Silverstein SM, Heinssen R. Social cognition in schizophrenia: an NIMH workshop on definitions, assessment, and research opportunities. Schizophrenia Bulletin. 34: 1211-20. PMID 18184635 DOI: 10.1093/Schbul/Sbm145  0.17
2012 Horan WP, Green MF, DeGroot M, Fiske A, Hellemann G, Kee K, Kern RS, Lee J, Sergi MJ, Subotnik KL, Sugar CA, Ventura J, Nuechterlein KH. Social cognition in schizophrenia, Part 2: 12-month stability and prediction of functional outcome in first-episode patients. Schizophrenia Bulletin. 38: 865-72. PMID 21382881 DOI: 10.1093/Schbul/Sbr001  0.169
2013 Jahshan C, Wynn JK, Green MF. Relationship between auditory processing and affective prosody in schizophrenia. Schizophrenia Research. 143: 348-53. PMID 23276478 DOI: 10.1016/J.Schres.2012.11.025  0.169
2013 Harvey PO, Zaki J, Lee J, Ochsner K, Green MF. Neural substrates of empathic accuracy in people with schizophrenia. Schizophrenia Bulletin. 39: 617-28. PMID 22451493 DOI: 10.1093/Schbul/Sbs042  0.169
2002 Raine A, Green MF. Schizophrenia and schizotypal personality: a tribute to Peter H. Venables. Schizophrenia Research. 54: 1-5. PMID 11853972 DOI: 10.1016/S0920-9964(01)00345-0  0.169
1994 Green MF, Nuechterlein KH, Mintz J. Backward masking in schizophrenia and mania. I. Specifying a mechanism. Archives of General Psychiatry. 51: 939-44. PMID 7979881 DOI: 10.1001/Archpsyc.1994.03950120011003  0.168
2012 Jahshan C, Wynn JK, Breitmeyer BG, Green MF. Nonconscious and conscious color priming in schizophrenia. Journal of Psychiatric Research. 46: 1312-7. PMID 22785333 DOI: 10.1016/J.Jpsychires.2012.06.009  0.168
2019 Reddy LF, Irwin MR, Breen EC, Reavis EA, Green MF. Social exclusion in schizophrenia: Psychological and cognitive consequences. Journal of Psychiatric Research. 114: 120-125. PMID 31059992 DOI: 10.1016/J.Jpsychires.2019.04.010  0.168
2012 Green MF, Bearden CE, Cannon TD, Fiske AP, Hellemann GS, Horan WP, Kee K, Kern RS, Lee J, Sergi MJ, Subotnik KL, Sugar CA, Ventura J, Yee CM, Nuechterlein KH. Social cognition in schizophrenia, Part 1: performance across phase of illness. Schizophrenia Bulletin. 38: 854-64. PMID 21345917 DOI: 10.1093/Schbul/Sbq171  0.168
2015 Greenwood TA, Lazzeroni LC, Calkins ME, Freedman R, Green MF, Gur RE, Gur RC, Light GA, Nuechterlein KH, Olincy A, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Stone WS, et al. Genetic assessment of additional endophenotypes from the Consortium on the Genetics of Schizophrenia Family Study. Schizophrenia Research. PMID 26597662 DOI: 10.1016/J.Schres.2015.11.008  0.168
2011 Lee J, Zaki J, Harvey PO, Ochsner K, Green MF. Schizophrenia patients are impaired in empathic accuracy. Psychological Medicine. 41: 2297-304. PMID 21524334 DOI: 10.1017/S0033291711000614  0.168
1992 Liberman RP, Green MF. Whither cognitive-behavioral therapy for schizophrenia? Schizophrenia Bulletin. 18: 27-35. PMID 1553496 DOI: 10.1093/Schbul/18.1.27  0.168
2003 Green MF, Nuechterlein KH, Breitmeyer B, Tsuang J, Mintz J. Forward and backward visual masking in schizophrenia: influence of age. Psychological Medicine. 33: 887-95. PMID 12877403 DOI: 10.1017/S003329170200716X  0.168
1994 Corrigan PW, Green MF, Toomey R. Cognitive correlates to social cue perception in schizophrenia. Psychiatry Research. 53: 141-51. PMID 7824674 DOI: 10.1016/0165-1781(94)90105-8  0.167
2014 Reddy LF, Horan WP, Jahshan C, Green MF. Cognitive Remediation for Schizophrenia: A Review of Recent Findings Current Treatment Options in Psychiatry. 1: 121-133. DOI: 10.1007/S40501-014-0011-8  0.167
2004 Green MF, Nuechterlein KH, Gold JM, Barch DM, Cohen J, Essock S, Fenton WS, Frese F, Goldberg TE, Heaton RK, Keefe RS, Kern RS, Kraemer H, Stover E, Weinberger DR, et al. Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria. Biological Psychiatry. 56: 301-7. PMID 15336511 DOI: 10.1016/J.Biopsych.2004.06.023  0.167
2018 Jahshan C, Vinogradov S, Wynn JK, Hellemann G, Green MF. A randomized controlled trial comparing a "bottom-up" and "top-down" approach to cognitive training in schizophrenia. Journal of Psychiatric Research. 109: 118-125. PMID 30529836 DOI: 10.1016/J.Jpsychires.2018.11.027  0.167
2005 Wynn JK, Light GA, Breitmeyer B, Nuechterlein KH, Green MF. Event-related gamma activity in schizophrenia patients during a visual backward-masking task. The American Journal of Psychiatry. 162: 2330-6. PMID 16330598 DOI: 10.1176/Appi.Ajp.162.12.2330  0.167
1991 Green M, Nuechterlein K. Backward masking deficits in schizophrenia: Implicating a mechanism Schizophrenia Research. 4: 384. DOI: 10.1016/0920-9964(91)90321-H  0.166
2014 Horan WP, Wynn JK, Mathis I, Miller GA, Green MF. Approach and withdrawal motivation in schizophrenia: an examination of frontal brain asymmetric activity. Plos One. 9: e110007. PMID 25310340 DOI: 10.1371/Journal.Pone.0110007  0.166
2020 McGovern JE, Reddy LF, Reavis EA, Green MF. Pupillary change on a cognitive effort task in schizophrenia: Associations with cognition and motivation. International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology. PMID 32413373 DOI: 10.1016/J.Ijpsycho.2020.05.003  0.166
2008 Wynn JK, Lee J, Horan WP, Green MF. Using event related potentials to explore stages of facial affect recognition deficits in schizophrenia. Schizophrenia Bulletin. 34: 679-87. PMID 18499704 DOI: 10.1093/Schbul/Sbn047  0.166
1995 Green M, Nuechterlein K, Breitmeyer B. Backward masking performance as an indicator of vulnerability to schizophrenia Schizophrenia Research. 15: 119. DOI: 10.1016/0920-9964(95)95366-H  0.165
2015 McCleery A, Green MF, Hellemann GS, Baade LE, Gold JM, Keefe RS, Kern RS, Mesholam-Gately RI, Seidman LJ, Subotnik KL, Ventura J, Nuechterlein KH. Latent structure of cognition in schizophrenia: a confirmatory factor analysis of the MATRICS Consensus Cognitive Battery (MCCB). Psychological Medicine. 1. PMID 26537981 DOI: 10.1017/S0033291715002433  0.165
2019 Green MF. From Social Cognition to Negative Symptoms in Schizophrenia: How Do We Get There From Here? Schizophrenia Bulletin. PMID 31776580 DOI: 10.1093/Schbul/Sbz113  0.165
2004 Green MF, Kern RS, Heaton RK. Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS. Schizophrenia Research. 72: 41-51. PMID 15531406 DOI: 10.1016/J.Schres.2004.09.009  0.165
2010 Kern RS, Gold JM, Dickinson D, Green MF, Nuechterlein KH, Keefe RS, Marder SR, Sugar CA. COGNITIVE DYSFUNCTION AND COMMUNITY FUNCTIONING IN SCHIZOPHRENIA: RESULTS FROM THE MATRICS PSYCHOMETRIC AND STANDARDIZATION STUDY (PASS) Schizophrenia Research. 117: 323-324. DOI: 10.1016/J.Schres.2010.02.551  0.165
2008 HORAN WP, KERN RS, GREEN MF, PENN DL. Social Cognition Training for Individuals with Schizophrenia: Emerging Evidence American Journal of Psychiatric Rehabilitation. 11: 205-252. DOI: 10.1080/15487760801963652  0.165
1993 Green MF. Cognitive remediation in schizophrenia: is it time yet? The American Journal of Psychiatry. 150: 178-87. PMID 8422068 DOI: 10.1176/ajp.150.2.178  0.164
2019 Jimenez AM, Riedel P, Lee J, Reavis EA, Green MF. Linking resting-state networks and social cognition in schizophrenia and bipolar disorder. Human Brain Mapping. PMID 31322784 DOI: 10.1002/Hbm.24731  0.164
1999 Subotnik KL, Nuechterlein KH, Green MF. Trait versus state aspects of the MMPI during the early course of schizophrenia. Journal of Psychiatric Research. 33: 275-84. PMID 10367994 DOI: 10.1016/S0022-3956(98)00062-4  0.164
2011 Green MF, Wynn JK, Breitmeyer B, Mathis KI, Nuechterlein KH. Visual masking by object substitution in schizophrenia. Psychological Medicine. 41: 1489-96. PMID 21078224 DOI: 10.1017/S003329171000214X  0.164
2017 Swerdlow NR, Light GA, Thomas ML, Sprock J, Calkins ME, Green MF, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Nuechterlein KH, Radant AD, Seidman LJ, Siever LJ, Silverman JM, et al. Deficient prepulse inhibition in schizophrenia in a multi-site cohort: Internal replication and extension. Schizophrenia Research. PMID 28549722 DOI: 10.1016/J.Schres.2017.05.013  0.164
2009 Horan WP, Nuechterlein KH, Wynn JK, Lee J, Castelli F, Green MF. Disturbances in the spontaneous attribution of social meaning in schizophrenia. Psychological Medicine. 39: 635-43. PMID 18606048 DOI: 10.1017/S0033291708003838  0.164
2000 Green M, Nuechterlein K, Breitmeyer B, Mintz J. 88. Perceptual deficits in schizophrenia may be explained by aberrant gamma range oscillations Biological Psychiatry. 47: S27. DOI: 10.1016/S0006-3223(00)00350-4  0.164
2003 Wynn J, Dawson M, Schell A, McGee M, Salveson D, Green M. Prepulse facilitation deficits in a passive task in schizophrenia patients and their siblings Schizophrenia Research. 60: 264. DOI: 10.1016/S0920-9964(03)80405-X  0.164
2007 Greenwood TA, Braff DL, Light GA, Cadenhead KS, Calkins ME, Dobie DJ, Freedman R, Green MF, Gur RE, Gur RC, Mintz J, Nuechterlein KH, Olincy A, Radant AD, Seidman LJ, et al. Initial heritability analyses of endophenotypic measures for schizophrenia: the consortium on the genetics of schizophrenia. Archives of General Psychiatry. 64: 1242-50. PMID 17984393 DOI: 10.1001/Archpsyc.64.11.1242  0.163
2016 Reavis EA, Lee J, Wynn JK, Engel SA, Jimenez AM, Green MF. Cortical Thickness of Functionally Defined Visual Areas in Schizophrenia and Bipolar Disorder. Cerebral Cortex (New York, N.Y. : 1991). PMID 27226446 DOI: 10.1167/16.12.1316  0.163
2014 Green M, Lee J, Horan WP, Harvey P. NEUROSCIENTIFIC EXPLORATIONS OF TWO LEVELS OF SOCIAL COGNITION IN SCHIZOPHRENIA Schizophrenia Research. 153: S4. DOI: 10.1016/S0920-9964(14)70012-X  0.163
2010 Yee CM, Mathis KI, Sun JC, Sholty GL, Lang PJ, Bachman P, Williams TJ, Bearden CE, Cannon TD, Green MF, Subotnik KL, Ventura J, Nuechterlein KH. Integrity of emotional and motivational states during the prodromal, first-episode, and chronic phases of schizophrenia. Journal of Abnormal Psychology. 119: 71-82. PMID 20141244 DOI: 10.1037/A0018475  0.162
2011 Horan WP, Harvey PO, Kern RS, Green MF. Neurocognition, Social Cognition and Functional Outcome in Schizophrenia Schizophrenia: Current Science and Clinical Practice. 67-107. DOI: 10.1002/9780470978672.ch3  0.162
2001 Brekke JS, Kohrt B, Green MF. Neuropsychological functioning as a moderator of the relationship between psychosocial functioning and the subjective experience of self and life in schizophrenia. Schizophrenia Bulletin. 27: 697-708. PMID 11824495 DOI: 10.1093/Oxfordjournals.Schbul.A006908  0.162
2011 Rassovsky Y, Horan WP, Lee J, Sergi MJ, Green MF. Pathways between early visual processing and functional outcome in schizophrenia. Psychological Medicine. 41: 487-97. PMID 20482936 DOI: 10.1017/S0033291710001054  0.162
2015 Tabak NT, Horan WP, Green MF. Mindfulness in schizophrenia: Associations with self-reported motivation, emotion regulation, dysfunctional attitudes, and negative symptoms. Schizophrenia Research. PMID 26232242 DOI: 10.1016/J.Schres.2015.07.030  0.162
2019 Wynn JK, Roach BJ, McCleery A, Marder SR, Mathalon DH, Green MF. Evaluating visual neuroplasticity with EEG in schizophrenia outpatients. Schizophrenia Research. PMID 31434625 DOI: 10.1016/J.Schres.2019.08.015  0.161
2001 Wiedl KH, Wienöbst J, Schöttke HH, Green MF, Nuechterlein KH. Attentional characteristics of schizophrenia patients differing in learning proficiency on the Wisconsin Card Sorting Test. Schizophrenia Bulletin. 27: 687-95. PMID 11824494 DOI: 10.1093/Oxfordjournals.Schbul.A006907  0.161
2015 Lee J, Green MF, Calkins ME, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Light GA, Nuechterlein KH, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Sprock J, Stone WS, et al. Verbal working memory in schizophrenia from the Consortium on the Genetics of Schizophrenia (COGS) study: the moderating role of smoking status and antipsychotic medications. Schizophrenia Research. 163: 24-31. PMID 25248939 DOI: 10.1016/J.Schres.2014.08.014  0.161
2017 Reddy F, Reavis E, Polon N, Morales J, Green M. 102. The Cognitive Costs of Social Exclusion in Schizophrenia Schizophrenia Bulletin. 43: S54-S54. DOI: 10.1093/Schbul/Sbx021.140  0.161
2015 Uemura T, Green M, Warsh JJ. CACNA1C SNP rs1006737 associates with bipolar I disorder independent of the Bcl-2 SNP rs956572 variant and its associated effect on intracellular calcium homeostasis. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 1-10. PMID 25843436 DOI: 10.3109/15622975.2015.1019360  0.161
2005 Wynn JK, Sergi MJ, Dawson ME, Schell AM, Green MF. Sensorimotor gating, orienting and social perception in schizophrenia. Schizophrenia Research. 73: 319-25. PMID 15653277 DOI: 10.1016/J.Schres.2004.07.013  0.161
2008 Nuechterlein KH, Green MF, Kern RS, Baade LE, Barch DM, Cohen JD, Essock S, Fenton WS, Frese FJ, Gold JM, Goldberg T, Heaton RK, Keefe RS, Kraemer H, Mesholam-Gately R, et al. The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity. The American Journal of Psychiatry. 165: 203-13. PMID 18172019 DOI: 10.1176/Appi.Ajp.2007.07010042  0.16
2012 Lin YC, Wynn JK, Hellemann G, Green MF. Factor structure of emotional intelligence in schizophrenia. Schizophrenia Research. 139: 78-81. PMID 22584064 DOI: 10.1016/J.Schres.2012.04.013  0.16
2019 Mccleery A, Wynn J, Jahshan C, Marder S, Roach B, Mathalon D, Green MF. 39.4 EARLY AUDITORY PROCESSING IN SCHIZOPHRENIA: RELATIONSHIPS TO CLINICAL SYMPTOMS AND COGNITIVE REMEDIATION Schizophrenia Bulletin. 45: S152-S153. DOI: 10.1093/Schbul/Sbz022.162  0.16
2015 Rodriguez-Jimenez R, Dompablo M, Bagney A, Santabárbara J, Aparicio AI, Torio I, Moreno-Ortega M, Lopez-Anton R, Lobo A, Kern RS, Green MF, Jimenez-Arriero MA, Santos JL, Nuechterlein KH, Palomo T. The MCCB impairment profile in a Spanish sample of patients with schizophrenia: Effects of diagnosis, age, and gender on cognitive functioning. Schizophrenia Research. PMID 26416441 DOI: 10.1016/J.Schres.2015.09.013  0.16
2009 Kee KS, Horan WP, Salovey P, Kern RS, Sergi MJ, Fiske AP, Lee J, Subotnik KL, Nuechterlein K, Sugar CA, Green MF. Emotional intelligence in schizophrenia. Schizophrenia Research. 107: 61-8. PMID 18805674 DOI: 10.1016/J.Schres.2008.08.016  0.16
2005 Brekke JS, Nakagami E, Kee KS, Green MF. Cross-ethnic differences in perception of emotion in schizophrenia. Schizophrenia Research. 77: 289-98. PMID 15923111 DOI: 10.1016/J.Schres.2005.04.004  0.16
2011 Harvey PO, Lee J, Cohen MS, Engel SA, Glahn DC, Nuechterlein KH, Wynn JK, Green MF. Altered dynamic coupling of lateral occipital complex during visual perception in schizophrenia. Neuroimage. 55: 1219-26. PMID 21194569 DOI: 10.1016/J.Neuroimage.2010.12.045  0.16
2000 Green MF, Kern RS, Braff DL, Mintz J. Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"? Schizophrenia Bulletin. 26: 119-36. PMID 10755673 DOI: 10.1093/Oxfordjournals.Schbul.A033430  0.159
2003 Green MF, Mintz J, Salveson D, Nuechterlein KH, Breitmeyer B, Light GA, Braff DL. Visual masking as a probe for abnormal gamma range activity in schizophrenia. Biological Psychiatry. 53: 1113-9. PMID 12814862 DOI: 10.1016/S0006-3223(02)01813-9  0.159
2014 Hamilton HK, Sun JC, Green MF, Kee KS, Lee J, Sergi M, Sholty GL, Mathis KI, Jetton C, Williams TJ, Kern R, Horan W, Fiske A, Subotnik KL, Ventura J, et al. Social cognition and functional outcome in schizophrenia: The moderating role of cardiac vagal tone. Journal of Abnormal Psychology. 123: 764-70. PMID 25314266 DOI: 10.1037/A0037813  0.159
2007 Green MF, Olivier B, Crawley JN, Penn DL, Silverstein S. Social cognition in schizophrenia: Recommandations from the measurement and treatment research to improve cognition in schizophrenia new approaches conference | Cognition sociale et schizophrénie: Recommandations de la conférence sur les nouvelles approches MATRICS Information Psychiatrique. 83: 99-106. DOI: 10.1684/ipe.2007.0093  0.159
2014 Reddy LF, Lee J, Davis MC, Altshuler L, Glahn DC, Miklowitz DJ, Green MF. Impulsivity and risk taking in bipolar disorder and schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 456-63. PMID 23963117 DOI: 10.1038/Npp.2013.218  0.158
2000 Harvey PD, Green MF. 380. Functional deficit in schizophrenia: course, correlates, and etiological factors Biological Psychiatry. 47: S116. DOI: 10.1016/S0006-3223(00)00644-2  0.158
2017 Mucci A, Galderisi S, Green MF, Nuechterlein K, Rucci P, Gibertoni D, Rossi A, Rocca P, Bertolino A, Bucci P, Hellemann G, Spisto M, Palumbo D, Aguglia E, Amodeo G, et al. Familial aggregation of MATRICS Consensus Cognitive Battery scores in a large sample of outpatients with schizophrenia and their unaffected relatives. Psychological Medicine. 1-10. PMID 29017620 DOI: 10.1017/S0033291717002902  0.158
2009 Green MF, Lee J, Cohen MS, Engel SA, Korb AS, Nuechterlein KH, Wynn JK, Glahn DC. Functional neuroanatomy of visual masking deficits in schizophrenia. Archives of General Psychiatry. 66: 1295-303. PMID 19996034 DOI: 10.1001/Archgenpsychiatry.2009.132  0.158
2011 Mathis KI, Wynn JK, Breitmeyer B, Nuechterlein KH, Green MF. The attentional blink in schizophrenia: isolating the perception/attention interface. Journal of Psychiatric Research. 45: 1346-51. PMID 21550051 DOI: 10.1016/J.Jpsychires.2011.04.002  0.158
2008 Nuechterlein K, Pashler H, Subotnik K, Green M, Cannon T, Bearden C. TRANSLATIONAL RESEARCH TO PROBE ATTENTIONAL DEFICITS IN SCHIZOPHRENIA: DUAL-TASK INTERFERENCE IN PRODROMAL, FIRST EPISODE, AND CHRONIC PHASES OF SCHIZOPHRENIA Schizophrenia Research. 102: 124. DOI: 10.1016/S0920-9964(08)70376-1  0.158
2006 Sergi MJ, Rassovsky Y, Nuechterlein KH, Green MF. Social perception as a mediator of the influence of early visual processing on functional status in schizophrenia. The American Journal of Psychiatry. 163: 448-54. PMID 16513866 DOI: 10.1176/Appi.Ajp.163.3.448  0.157
2007 Keefe RS, Bilder RM, Davis SM, Harvey PD, Palmer BW, Gold JM, Meltzer HY, Green MF, Capuano G, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, Davis CE, et al. Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial. Archives of General Psychiatry. 64: 633-47. PMID 17548746 DOI: 10.1001/Archpsyc.64.6.633  0.157
1996 Green MF. What are the functional consequences of neurocognitive deficits in schizophrenia? The American Journal of Psychiatry. 153: 321-30. PMID 8610818 DOI: 10.1176/Ajp.153.3.321  0.157
1991 Nuechterlein KH, Green MF. Neuropsychological vulnerability or episode factors in schizophrenia? Behavioral and Brain Sciences. 14: 37-38. DOI: 10.1017/S0140525X00065250  0.157
2007 Sergi MJ, Rassovsky Y, Widmark C, Reist C, Erhart S, Braff DL, Marder SR, Green MF. Social cognition in schizophrenia: relationships with neurocognition and negative symptoms. Schizophrenia Research. 90: 316-24. PMID 17141477 DOI: 10.1016/J.Schres.2006.09.028  0.157
2014 Horan WP, Iacoboni M, Cross KA, Korb A, Lee J, Nori P, Quintana J, Wynn JK, Green MF. Self-reported empathy and neural activity during action imitation and observation in schizophrenia. Neuroimage. Clinical. 5: 100-8. PMID 25009771 DOI: 10.1016/J.Nicl.2014.06.006  0.157
2012 Green MF, Hellemann G, Horan WP, Lee J, Wynn JK. From perception to functional outcome in schizophrenia: modeling the role of ability and motivation. Archives of General Psychiatry. 69: 1216-24. PMID 23026889 DOI: 10.1001/Archgenpsychiatry.2012.652  0.157
2016 Horan WP, Wynn JK, Hajcak G, Altshuler L, Green MF. Distinct Patterns of Dysfunctional Appetitive and Aversive Motivation in Bipolar Disorder Versus Schizophrenia: An Event-Related Potential Study. Journal of Abnormal Psychology. PMID 26845261 DOI: 10.1037/Abn0000142  0.157
1999 Wirshing DA, Marshall BD, Green MF, Mintz J, Marder SR, Wirshing WC. Risperidone in treatment-refractory schizophrenia. The American Journal of Psychiatry. 156: 1374-9. PMID 10484947 DOI: 10.1176/Ajp.156.9.1374  0.156
2006 Green MF. Cognitive Impairment and Functional Outcome in Schizophrenia and Bipolar Disorder The Journal of Clinical Psychiatry. 67: e12. DOI: 10.4088/JCP.1006e12  0.156
2006 Løberg EM, Jørgensen HA, Green MF, Rund BR, Lund A, Diseth A, Oie M, Hugdahl K. Positive symptoms and duration of illness predict functional laterality and attention modulation in schizophrenia. Acta Psychiatrica Scandinavica. 113: 322-31. PMID 16638077 DOI: 10.1111/J.1600-0447.2005.00627.X  0.156
2015 Stone WS, Mesholam-Gately RI, Braff DL, Calkins ME, Freedman R, Green MF, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Light GA, Nuechterlein KH, Olincy A, Radant AD, Siever LJ, et al. California Verbal Learning Test-II performance in schizophrenia as a function of ascertainment strategy: comparing the first and second phases of the Consortium on the Genetics of Schizophrenia (COGS). Schizophrenia Research. 163: 32-7. PMID 25497440 DOI: 10.1016/J.Schres.2014.10.029  0.156
2005 Buchanan RW, Davis M, Goff D, Green MF, Keefe RS, Leon AC, Nuechterlein KH, Laughren T, Levin R, Stover E, Fenton W, Marder SR. A summary of the FDA-NIMH-MATRICS workshop on clinical trial design for neurocognitive drugs for schizophrenia. Schizophrenia Bulletin. 31: 5-19. PMID 15888422 DOI: 10.1093/Schbul/Sbi020  0.156
1992 Green MF, Satz P, Ganzell S, Vaclav JF. Wisconsin Card Sorting Test performance in schizophrenia: remediation of a stubborn deficit. The American Journal of Psychiatry. 149: 62-7. PMID 1728187 DOI: 10.1176/ajp.149.1.62  0.155
1998 Hellman SG, Kern RS, Neilson LM, Green MF. Monetary reinforcement and Wisconsin Card Sorting performance in schizophrenia: why show me the money? Schizophrenia Research. 34: 67-75. PMID 9824878 DOI: 10.1016/S0920-9964(98)00088-7  0.155
2012 Horan WP, Kern R, Green MF. SOCIAL COGNITIVE SKILLS TRAINING FOR SCHIZOPHRENIA: INITIAL EFFICACY AND WAYS TO AUGMENT THE EFFECTS Schizophrenia Research. 136: S39. DOI: 10.1016/S0920-9964(12)70141-X  0.155
2004 Kern RS, Green MF, Nuechterlein KH, Deng BH. NIMH-MATRICS survey on assessment of neurocognition in schizophrenia. Schizophrenia Research. 72: 11-9. PMID 15531403 DOI: 10.1016/J.Schres.2004.09.004  0.155
2013 Wynn JK, Mathis KI, Ford J, Breitmeyer BG, Green MF. Object substitution masking in schizophrenia: an event-related potential analysis. Frontiers in Psychology. 4: 30. PMID 23382723 DOI: 10.3389/Fpsyg.2013.00030  0.155
2013 Gohar SM, Hamdi E, El Ray LA, Horan WP, Green MF. Adapting and evaluating a social cognitive remediation program for schizophrenia in Arabic. Schizophrenia Research. 148: 12-7. PMID 23756297 DOI: 10.1016/J.Schres.2013.05.008  0.154
2017 Jahshan C, Rassovsky Y, Green MF. Enhancing Neuroplasticity to Augment Cognitive Remediation in Schizophrenia. Frontiers in Psychiatry. 8: 191. PMID 29021765 DOI: 10.3389/Fpsyt.2017.00191  0.154
2005 Brekke J, Kay DD, Lee KS, Green MF. Biosocial pathways to functional outcome in schizophrenia. Schizophrenia Research. 80: 213-25. PMID 16137859 DOI: 10.1016/J.Schres.2005.07.008  0.154
2014 McCleery A, Horan WP, Green MF. Social Cognition during the Early Phase of Schizophrenia Social Cognition and Metacognition in Schizophrenia: Psychopathology and Treatment Approaches. 49-67. DOI: 10.1016/B978-0-12-405172-0.00003-X  0.154
1994 Corrigan PW, Wallace CJ, Schade ML, Green MF. Learning medication self-management skills in schizophrenia: Relationships with cognitive deficits and psychiatric symptoms Behavior Therapy. 25: 5-15. DOI: 10.1016/S0005-7894(05)80142-X  0.154
2013 Strauss GP, Horan WP, Kirkpatrick B, Fischer BA, Keller WR, Miski P, Buchanan RW, Green MF, Carpenter WT. Deconstructing negative symptoms of schizophrenia: avolition-apathy and diminished expression clusters predict clinical presentation and functional outcome. Journal of Psychiatric Research. 47: 783-90. PMID 23453820 DOI: 10.1016/J.Jpsychires.2013.01.015  0.154
2010 Wynn JK, Horan WP, Kring AM, Simons RF, Green MF. Impaired anticipatory event-related potentials in schizophrenia. International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology. 77: 141-9. PMID 20573584 DOI: 10.1016/J.Ijpsycho.2010.05.009  0.154
2009 Green MF. New possibilities in cognition enhancement for schizophrenia. The American Journal of Psychiatry. 166: 749-52. PMID 19570935 DOI: 10.1176/Appi.Ajp.2009.09050610  0.154
2015 Wu JQ, Green MJ, Gardiner EJ, Tooney PA, Scott RJ, Carr VJ, Cairns MJ. Altered neural signaling and immune pathways in peripheral blood mononuclear cells of schizophrenia patients with cognitive impairment: A transcriptome analysis Brain, Behavior, and Immunity. DOI: 10.1016/j.bbi.2015.12.010  0.154
2008 Green MF, Nuechterlein KH, Kern RS, Baade LE, Fenton WS, Gold JM, Keefe RS, Mesholam-Gately R, Seidman LJ, Stover E, Marder SR. Functional co-primary measures for clinical trials in schizophrenia: results from the MATRICS Psychometric and Standardization Study. The American Journal of Psychiatry. 165: 221-8. PMID 18172017 DOI: 10.1176/Appi.Ajp.2007.07010089  0.154
2011 Green MF, Lee J, Wynn JK, Mathis KI. Visual masking in schizophrenia: overview and theoretical implications. Schizophrenia Bulletin. 37: 700-8. PMID 21606322 DOI: 10.1093/Schbul/Sbr051  0.154
2015 McCleery A, Lee J, Joshi A, Wynn JK, Hellemann GS, Green MF. Meta-analysis of face processing event-related potentials in schizophrenia. Biological Psychiatry. 77: 116-26. PMID 24923618 DOI: 10.1016/J.Biopsych.2014.04.015  0.154
2014 Wynn JK, Jahshan C, Green MF. Multisensory integration in schizophrenia: a behavioural and event-related potential study. Cognitive Neuropsychiatry. 19: 319-36. PMID 24397788 DOI: 10.1080/13546805.2013.866892  0.153
2003 Kern RS, Green MF, Mintz J, Liberman RP. Does 'errorless learning' compensate for neurocognitive impairments in the work rehabilitation of persons with schizophrenia? Psychological Medicine. 33: 433-42. PMID 12701664 DOI: 10.1017/S0033291702007298  0.153
2016 Lee J, Rizzo S, Altshuler L, Glahn DC, Miklowitz DJ, Sugar CA, Wynn JK, Green MF. Deconstructing Bipolar Disorder and Schizophrenia: A cross-diagnostic cluster analysis of cognitive phenotypes. Journal of Affective Disorders. 209: 71-79. PMID 27888723 DOI: 10.1016/J.Jad.2016.11.030  0.153
2015 Laurens KR, Luo L, Matheson SL, Carr VJ, Raudino A, Harris F, Green MJ. Common or distinct pathways to psychosis? A systematic review of evidence from prospective studies for developmental risk factors and antecedents of the schizophrenia spectrum disorders and affective psychoses. Bmc Psychiatry. 15: 205. PMID 26302744 DOI: 10.1186/S12888-015-0562-2  0.153
2010 Green MF, Schooler NR, Kern RS, Seidman L, Sonnenberg J, Stone W, Walling D. VALIDATION OF INTERMEDIATE (CO-PRIMARY) MEASURES FOR CLINICAL TRIALS OF COGNITION-ENHANCING DRUGS FOR SCHIZOPHRENIA Schizophrenia Research. 117: 119-120. DOI: 10.1016/J.Schres.2010.02.054  0.153
2011 Reise SP, Ventura J, Keefe RS, Baade LE, Gold JM, Green MF, Kern RS, Mesholam-Gately R, Nuechterlein KH, Seidman LJ, Bilder R. Bifactor and item response theory analyses of interviewer report scales of cognitive impairment in schizophrenia. Psychological Assessment. 23: 245-61. PMID 21381848 DOI: 10.1037/A0021501  0.153
2017 Jimenez AM, Lee J, Green MF, Wynn JK. Functional connectivity when detecting rare visual targets in schizophrenia. Psychiatry Research. 261: 35-43. PMID 28126618 DOI: 10.1016/J.Pscychresns.2017.01.007  0.153
1992 Kim D, Raine A, Triphon N, Green MF. Mixed handedness and features of schizotypal personality in a nonclinical sample. The Journal of Nervous and Mental Disease. 180: 133-5. PMID 1737976 DOI: 10.1097/00005053-199202000-00012  0.152
2016 McCleery A, Lee J, Fiske AP, Ghermezi L, Hayata JN, Hellemann GS, Horan WP, Kee KS, Kern RS, Knowlton BJ, Subotnik KL, Ventura J, Sugar CA, Nuechterlein KH, Green MF. Longitudinal stability of social cognition in schizophrenia: A 5-year follow-up of social perception and emotion processing. Schizophrenia Research. PMID 27443808 DOI: 10.1016/J.Schres.2016.07.008  0.152
2007 Brekke JS, Hoe M, Long J, Green MF. How neurocognition and social cognition influence functional change during community-based psychosocial rehabilitation for individuals with schizophrenia. Schizophrenia Bulletin. 33: 1247-56. PMID 17255120 DOI: 10.1093/Schbul/Sbl072  0.152
2015 Green MF, Horan WP, Lee J. Social cognition in schizophrenia. Nature Reviews. Neuroscience. PMID 26373471 DOI: 10.1038/Nrn4005  0.152
1994 Nuechterlein KH, Dawson ME, Green MF. Information-processing abnormalities as neuropsychological vulnerability indicators for schizophrenia. Acta Psychiatrica Scandinavica. Supplementum. 384: 71-9. PMID 7879647 DOI: 10.1111/J.1600-0447.1994.Tb05894.X  0.152
1994 Green MF, Nuechterlein KH, Mintz J. Backward masking in schizophrenia and mania. II. Specifying the visual channels. Archives of General Psychiatry. 51: 945-51. PMID 7979882 DOI: 10.1001/Archpsyc.1994.03950120017004  0.152
2010 Lee J, Cohen MS, Engel SA, Glahn D, Nuechterlein KH, Wynn JK, Green MF. Regional brain activity during early visual perception in unaffected siblings of schizophrenia patients. Biological Psychiatry. 68: 78-85. PMID 20494338 DOI: 10.1016/J.Biopsych.2010.03.028  0.151
2017 Jahshan C, Wynn JK, Dolinsky M, Mathalon D, Green MF. SA70. Cognitive Correlates of Visual Cortical Plasticity in Schizophrenia Schizophrenia Bulletin. 43: S138-S138. DOI: 10.1093/Schbul/Sbx023.069  0.151
2015 Reddy LF, Horan WP, Green MF. Motivational Deficits and Negative Symptoms in Schizophrenia: Concepts and Assessments. Current Topics in Behavioral Neurosciences. PMID 26164592 DOI: 10.1007/7854_2015_379  0.15
2006 Kern RS, Green MF, Marder SR. The NIMH MATRICS Initiative: Development of a Consensus Cognitive Battery Progress in Neurotherapeutics and Neuropsychopharmacology. 2: 173-186. DOI: 10.1017/S1748232106000127  0.15
2015 Wynn JK, Jimenez AM, Roach BJ, Korb A, Lee J, Horan WP, Ford JM, Green MF. Impaired target detection in schizophrenia and the ventral attentional network: Findings from a joint event-related potential-functional MRI analysis. Neuroimage. Clinical. 9: 95-102. PMID 26448909 DOI: 10.1016/J.Nicl.2015.07.004  0.15
2023 Dang M, Wang R, Lee HC, Patel KK, Becnel MR, Han G, Thomas SK, Hao D, Chu Y, Weber DM, Lin P, Lutter-Berka Z, Berrios Nolasco DA, Huang M, Bansal H, ... ... Green MR, et al. Single cell clonotypic and transcriptional evolution of multiple myeloma precursor disease. Cancer Cell. 41: 1032-1047.e4. PMID 37311413 DOI: 10.1016/j.ccell.2023.05.007  0.15
2015 Horan WP, Reddy LF, Barch DM, Buchanan RW, Dunayevich E, Gold JM, Marder SR, Wynn JK, Young JW, Green MF. Effort-Based Decision-Making Paradigms for Clinical Trials in Schizophrenia: Part 2-External Validity and Correlates. Schizophrenia Bulletin. PMID 26209546 DOI: 10.1093/Schbul/Sbv090  0.15
2017 Wynn JK, Green MF, Hellemann G, Karunaratne K, Davis MC, Marder SR. The effects of curcumin on brain-derived neurotrophic factor and cognition in schizophrenia: A randomized controlled study. Schizophrenia Research. PMID 28965778 DOI: 10.1016/J.Schres.2017.09.046  0.15
2013 Olbert CM, Penn DL, Kern RS, Lee J, Horan WP, Reise SP, Ochsner KN, Marder SR, Green MF. Adapting social neuroscience measures for schizophrenia clinical trials, part 3: fathoming external validity. Schizophrenia Bulletin. 39: 1211-8. PMID 24072806 DOI: 10.1093/Schbul/Sbt130  0.15
2012 Butler PD, Chen Y, Ford JM, Geyer MA, Silverstein SM, Green MF. Perceptual measurement in schizophrenia: promising electrophysiology and neuroimaging paradigms from CNTRICS. Schizophrenia Bulletin. 38: 81-91. PMID 21890745 DOI: 10.1093/Schbul/Sbr106  0.15
2011 Lee J, Gosselin F, Wynn JK, Green MF. How do schizophrenia patients use visual information to decode facial emotion? Schizophrenia Bulletin. 37: 1001-8. PMID 20156852 DOI: 10.1093/Schbul/Sbq006  0.15
2016 Llerena K, Wynn JK, Hajcak G, Green MF, Horan WP. Patterns and reliability of EEG during error monitoring for internal versus external feedback in schizophrenia. International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology. PMID 27166742 DOI: 10.1016/J.Ijpsycho.2016.04.012  0.149
2017 Rassovsky Y, Dunn W, Wynn J, Wu A, Iacoboni M, Hellemann G, Green M. M28. Effect of Transcranial Direct Current Stimulation on Neurocognition, Social Cognition, and EEG in Schizophrenia Schizophrenia Bulletin. 43: S221-S222. DOI: 10.1093/Schbul/Sbx022.027  0.149
2017 Reavis EA, Lee J, Wynn JK, Engel SA, Cohen MS, Nuechterlein KH, Glahn DC, Altshuler LL, Green MF. Assessing neural tuning for object perception in schizophrenia and bipolar disorder with multivariate pattern analysis of fMRI data. Neuroimage. Clinical. 16: 491-497. PMID 28932681 DOI: 10.1016/J.Nicl.2017.08.023  0.149
2012 Green M, Horan W. SOCIAL COGNITION SCHIZOPHRENIA: RATIONALE AND STRATEGIES FOR TRAINING INTERVENTION Schizophrenia Research. 136: S2-S3. DOI: 10.1016/S0920-9964(12)70009-9  0.149
2016 Olbert CM, Penn DL, Reise SP, Horan WP, Kern RS, Lee J, Green MF. Assessment of attachment in psychosis: A psychometric cause for concern. Psychiatry Research. 246: 77-83. PMID 27664549 DOI: 10.1016/J.Psychres.2016.09.020  0.148
1998 Subotnik KL, Nuechterlein KH, Ventura J, Green MF, Hwang SS. Prediction of the deficit syndrome from initial deficit symptoms in the early course of schizophrenia. Psychiatry Research. 80: 53-9. PMID 9727963 DOI: 10.1016/S0165-1781(98)00052-3  0.148
2012 Hoe M, Nakagami E, Green MF, Brekke JS. The causal relationships between neurocognition, social cognition and functional outcome over time in schizophrenia: a latent difference score approach. Psychological Medicine. 42: 2287-99. PMID 22475159 DOI: 10.1017/S0033291712000578  0.148
2003 Kee K, Brekke J, Seaborg P, Fish S, Deng B, Nori P, Green M. Motivation, symptomatology, and functional outcome in schizophrenia: What are the links? Schizophrenia Research. 60: 172. DOI: 10.1016/S0920-9964(03)81044-7  0.148
2012 Jahshan C, Wynn JK, Mathis KI, Altshuler LL, Glahn DC, Green MF. Cross-diagnostic comparison of duration mismatch negativity and P3a in bipolar disorder and schizophrenia. Bipolar Disorders. 14: 239-48. PMID 22548897 DOI: 10.1111/J.1399-5618.2012.01008.X  0.148
2016 Reddy LF, Green MF, Wynn JK, Rinck M, Horan WP. Approaching anger in schizophrenia: What an implicit task tells you that self-report does not. Schizophrenia Research. PMID 27242068 DOI: 10.1016/J.Schres.2016.05.018  0.148
2019 McGovern J, Reddy F, Reavis E, Wynn J, Ghazarian S, Tucker Z, Green MF. T30. ASSOCIATION OF PUPILLARY AND BEHAVIORAL COGNITIVE EFFORT INDICES WITH COGNITION AND FUNCTIONING IN INDIVIDUALS WITH SCHIZOPHRENIA Schizophrenia Bulletin. 45: S214-S215. DOI: 10.1093/Schbul/Sbz019.310  0.148
2013 Greenwood TA, Swerdlow NR, Gur RE, Cadenhead KS, Calkins ME, Dobie DJ, Freedman R, Green MF, Gur RC, Lazzeroni LC, Nuechterlein KH, Olincy A, Radant AD, Ray A, Schork NJ, et al. Genome-wide linkage analyses of 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia. The American Journal of Psychiatry. 170: 521-32. PMID 23511790 DOI: 10.1176/Appi.Ajp.2012.12020186  0.148
1989 Green MF, Kinsbourne M. Auditory hallucinations in schizophrenia: does humming help? Biological Psychiatry. 25: 633-5. PMID 2920196 DOI: 10.1016/0006-3223(89)90225-4  0.148
1985 Green M, Walker E. Neuropsychological performance and positive and negative symptoms in schizophrenia. Journal of Abnormal Psychology. 94: 460-469. DOI: 10.1037/0021-843X.94.4.460  0.148
2020 Kraus MS, Gold JM, Barch DM, Walker TM, Chun CA, Buchanan RW, Csernansky JG, Goff DC, Green MF, Jarskog LF, Javitt DC, Kimhy D, Lieberman JA, McEvoy JP, Mesholam-Gately RI, et al. The characteristics of cognitive neuroscience tests in a schizophrenia cognition clinical trial: Psychometric properties and correlations with standard measures. Schizophrenia Research. Cognition. 19: 100161. PMID 31832342 DOI: 10.1016/J.Scog.2019.100161  0.148
2016 Teroganova N, Girshkin L, Suter CM, Green MJ. DNA methylation in peripheral tissue of schizophrenia and bipolar disorder: a systematic review. Bmc Genetics. 17: 27. PMID 26809779 DOI: 10.1186/s12863-016-0332-2  0.148
2016 Lee J, Green MF. Social Preference and Glutamatergic Dysfunction: Underappreciated Prerequisites for Social Dysfunction in Schizophrenia. Trends in Neurosciences. PMID 27477199 DOI: 10.1016/J.Tins.2016.06.005  0.147
2010 Nuechterlein KH, Green MF, Kern RS. Schizophrenia as a cognitive disorder: Recent approaches to identifying its core cognitive components to aid treatment development Advances in Schizophrenia Research 2009. 267-282. DOI: 10.1007/978-1-4419-0913-8_14  0.147
2017 Horan WP, Johnson MW, Green MF. Altered Experiential, But Not Hypothetical, Delay Discounting in Schizophrenia. Journal of Abnormal Psychology. PMID 28165261 DOI: 10.1037/Abn0000249  0.147
2013 Horan WP, Hajcak G, Wynn JK, Green MF. Impaired emotion regulation in schizophrenia: evidence from event-related potentials. Psychological Medicine. 43: 2377-91. PMID 23360592 DOI: 10.1017/S0033291713000019  0.147
2016 Stone WS, Mesholam-Gately RI, Giuliano AJ, Woodberry KA, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Mathalon DH, McGlashan TH, Perkins DO, Tsuang MT, Walker EF, Woods SW, ... ... Green MF, et al. Healthy adolescent performance on the MATRICS Consensus Cognitive Battery (MCCB): Developmental data from two samples of volunteers. Schizophrenia Research. PMID 26896388 DOI: 10.1016/J.Schres.2016.02.003  0.147
2019 Yang YS, Maddock RJ, Lee J, Zhang H, Hellemann G, Narr KL, Marder SR, Green MF. Brain glutathione levels and age at onset of illness in chronic schizophrenia. Acta Neuropsychiatrica. 1-16. PMID 31364526 DOI: 10.1017/Neu.2019.29  0.147
2017 McCleery A, Wynn JK, Reavis E, Kutasevich E, Morales J, Roach BJ, Mathalon D, Green MF. M72. Cortical Plasticity in Schizophrenia: Associations With Cognition and Community Functioning Schizophrenia Bulletin. 43: S236-S237. DOI: 10.1093/Schbul/Sbx022.067  0.147
1989 Green MF, Satz P, Gaier DJ, Ganzell S, Kharabi F. Minor physical anomalies in schizophrenia. Schizophrenia Bulletin. 15: 91-9. PMID 2717891 DOI: 10.1093/Schbul/15.1.91  0.146
2012 Harvey P, Zaki l, Lee J, Ochsner K, Green MF. Poster #23 NEURAL SUBSTRATES OF EMPATHIC ACCURACY IN PEOPLE WITH SCHIZOPHRENIA Schizophrenia Research. 136: S289. DOI: 10.1016/S0920-9964(12)70856-3  0.146
2004 Rassovsky Y, Green MF, Nuechterlein KH, Breitmeyer B, Mintz J. Paracontrast and metacontrast in schizophrenia: clarifying the mechanism for visual masking deficits. Schizophrenia Research. 71: 485-92. PMID 15474919 DOI: 10.1016/J.Schres.2004.02.018  0.146
2003 Glahn D, Green M, Cohen A, McGee M. Contextual processing deficits in schizophrenia: Poor integration of visual information or reduced storage capacity Schizophrenia Research. 60: 135. DOI: 10.1016/S0920-9964(03)80929-5  0.146
2020 Catalano LT, Green MF, Wynn JK, Lee J. People with schizophrenia do not show the normal benefits of social versus nonsocial attentional cues. Neuropsychology. PMID 32338943 DOI: 10.1037/Neu0000642  0.146
2018 McCleery A, Wynn JK, Green MF. Hallucinations, neuroplasticity, and prediction errors in schizophrenia. Scandinavian Journal of Psychology. 59: 41-48. PMID 29356009 DOI: 10.1111/Sjop.12413  0.145
2015 Laurens KR, Luo L, Matheson SL, Carr VJ, Raudino A, Harris F, Green MJ. Common or distinct pathways to psychosis? A systematic review of evidence from prospective studies for developmental risk factors and antecedents of the schizophrenia spectrum disorders and affective psychoses Bmc Psychiatry. 15. DOI: 10.1186/s12888-015-0562-2  0.145
2006 Subotnik KL, Nuechterlein KH, Green MF, Horan WP, Nienow TM, Ventura J, Nguyen AT. Neurocognitive and social cognitive correlates of formal thought disorder in schizophrenia patients. Schizophrenia Research. 85: 84-95. PMID 16624529 DOI: 10.1016/J.Schres.2006.03.007  0.145
2011 Harvey PO, Lee J, Horan WP, Ochsner K, Green MF. Do patients with schizophrenia benefit from a self-referential memory bias? Schizophrenia Research. 127: 171-7. PMID 21147520 DOI: 10.1016/J.Schres.2010.11.011  0.145
2019 Jimenez AM, Riedel P, Humble J, Kozikowski S, Lee J, Reavis EA, Szewczyk W, Green MF. S168. Social Cognition and Resting State Networks in Schizophrenia and Bipolar Disorder Biological Psychiatry. 85: S362. DOI: 10.1016/J.Biopsych.2019.03.919  0.145
2018 Clayson PE, Kern RS, Nuechterlein KH, Knowlton BJ, Bearden CE, Cannon TD, Fiske AP, Ghermezi L, Hayata JN, Hellemann GS, Horan WP, Kee K, Lee J, Subotnik KL, Sugar CA, ... ... Green MF, et al. Social vs. non-social measures of learning potential for predicting community functioning across phase of illness in schizophrenia. Schizophrenia Research. PMID 30121183 DOI: 10.1016/J.Schres.2018.07.046  0.145
2003 Narr KL, Green MF, Capetillo-Cunliffe L, Toga AW, Zaidel E. Lateralized lexical decision in schizophrenia: hemispheric specialization and interhemispheric lexicality priming. Journal of Abnormal Psychology. 112: 623-32. PMID 14674874 DOI: 10.1037/0021-843X.112.4.623  0.145
2005 Evins AE, Deckersbach T, Cather C, Freudenreich O, Culhane MA, Henderson DC, Green MF, Schoenfeld DA, Rigotti NA, Goff DC. Independent effects of tobacco abstinence and bupropion on cognitive function in schizophrenia. The Journal of Clinical Psychiatry. 66: 1184-90. PMID 16187778 DOI: 10.4088/Jcp.V66N0915  0.145
2012 Horan WP, Foti D, Hajcak G, Wynn JK, Green MF. Corrigendum to "Intact motivated attention in schizophrenia: Evidence from event-related potentials" [Schizophrenia Research 135 (2012) 95-99] Schizophrenia Research. 141: 288-289. DOI: 10.1016/J.Schres.2012.08.004  0.145
1994 Green MF, Bracha HS, Satz P, Christenson CD. Preliminary evidence for an association between minor physical anomalies and second trimester neurodevelopment in schizophrenia. Psychiatry Research. 53: 119-27. PMID 7824672 DOI: 10.1016/0165-1781(94)90103-1  0.144
2007 Green MF. Cognition, drug treatment, and functional outcome in schizophrenia: a tale of two transitions. The American Journal of Psychiatry. 164: 992-4. PMID 17606645 DOI: 10.1176/Ajp.2007.164.7.992  0.144
2017 Horan WP, Green MF. Treatment of social cognition in schizophrenia: Current status and future directions. Schizophrenia Research. PMID 28712968 DOI: 10.1016/J.Schres.2017.07.013  0.144
2009 Green MF, Butler PD, Chen Y, Geyer MA, Silverstein S, Wynn JK, Yoon JH, Zemon V. Perception measurement in clinical trials of schizophrenia: promising paradigms from CNTRICS. Schizophrenia Bulletin. 35: 163-81. PMID 19023123 DOI: 10.1093/Schbul/Sbn156  0.144
2017 Reavis EA, Lee J, Wynn JK, Narr KL, Njau SN, Engel SA, Green MF. Linking optic radiation volume to visual perception in schizophrenia and bipolar disorder. Schizophrenia Research. PMID 28318839 DOI: 10.1016/J.Schres.2017.03.027  0.143
2017 Vaskinn A, Fiske AP, Green MF. Enhancing tolerability of a measure of social perception in schizophrenia: comparison of short and long Norwegian versions of the Relationships Across Domains test. Cognitive Neuropsychiatry. 1-9. PMID 28346041 DOI: 10.1080/13546805.2017.1307174  0.143
2012 Rassovsky Y, Lee J, Nori P, Wu AD, Iacoboni M, Green MF. Poster #73 SPATIAL AND TEMPORAL PROPERTIES OF AFFECT PERCEPTION DEFICITS IN SCHIZOPHRENIA: A TMS STUDY Schizophrenia Research. 136: S306-S307. DOI: 10.1016/S0920-9964(12)70906-4  0.143
2009 Horan WP, Kern RS, Shokat-Fadai K, Sergi MJ, Wynn JK, Green MF. Social cognitive skills training in schizophrenia: an initial efficacy study of stabilized outpatients. Schizophrenia Research. 107: 47-54. PMID 18930378 DOI: 10.1016/J.Schres.2008.09.006  0.143
1989 Green MF, Satz P, Smith C, Nelson L. Is there atypical handedness in schizophrenia? Journal of Abnormal Psychology. 98: 57-61. PMID 2708642 DOI: 10.1037//0021-843X.98.1.57  0.143
2008 Kern RS, Nuechterlein KH, Green MF, Baade LE, Fenton WS, Gold JM, Keefe RS, Mesholam-Gately R, Mintz J, Seidman LJ, Stover E, Marder SR. The MATRICS Consensus Cognitive Battery, part 2: co-norming and standardization. The American Journal of Psychiatry. 165: 214-20. PMID 18172018 DOI: 10.1176/Appi.Ajp.2007.07010043  0.143
2017 Buck B, Iwanski C, Healey KM, Green MF, Horan WP, Kern RS, Lee J, Marder SR, Reise SP, Penn DL. Improving measurement of attributional style in schizophrenia; A psychometric evaluation of the Ambiguous Intentions Hostility Questionnaire (AIHQ). Journal of Psychiatric Research. 89: 48-54. PMID 28160626 DOI: 10.1016/J.Jpsychires.2017.01.004  0.143
2016 Dunn W, Rassovsky Y, Wynn JK, Wu AD, Iacoboni M, Hellemann G, Green MF. Modulation of neurophysiological auditory processing measures by bilateral transcranial direct current stimulation in schizophrenia. Schizophrenia Research. PMID 27132485 DOI: 10.1016/J.Schres.2016.04.021  0.142
2017 Lee J, Nuechterlein KH, Knowlton BJ, Bearden CE, Cannon TD, Fiske AP, Ghermezi L, Hayata JN, Hellemann GS, Horan WP, Kee K, Kern RS, Subotnik KL, Sugar CA, Ventura J, ... Green MF, et al. Episodic Memory for Dynamic Social Interaction Across Phase of Illness in Schizophrenia. Schizophrenia Bulletin. PMID 29106694 DOI: 10.1093/Schbul/Sbx081  0.142
2014 Reddy LF, Horan WP, Green MF. Revisions and Refinements of the Diagnosis of Schizophrenia in DSM-5 Clinical Psychology: Science and Practice. 21: 236-244. DOI: 10.1111/Cpsp.12071  0.142
2008 Goff DC, Cather C, Gottlieb JD, Evins AE, Walsh J, Raeke L, Otto MW, Schoenfeld D, Green MF. Once-weekly D-cycloserine effects on negative symptoms and cognition in schizophrenia: an exploratory study. Schizophrenia Research. 106: 320-7. PMID 18799288 DOI: 10.1016/J.Schres.2008.08.012  0.142
2012 Green MF, Lee J. Neural bases of emotional experience versus perception in schizophrenia. Biological Psychiatry. 71: 96-7. PMID 22152783 DOI: 10.1016/J.Biopsych.2011.11.005  0.142
2018 Llerena K, Gabrielian S, Green MF. Clinical and cognitive correlates of unsheltered status in homeless persons with psychotic disorders. Schizophrenia Research. PMID 29486957 DOI: 10.1016/J.Schres.2018.02.023  0.142
1995 Fleming K, Green MF. Backward masking performance during and after manic episodes. Journal of Abnormal Psychology. 104: 63-8. PMID 7897054 DOI: 10.1037//0021-843X.104.1.63  0.142
2013 Wynn JK, Jahshan C, Altshuler LL, Glahn DC, Green MF. Event-related potential examination of facial affect processing in bipolar disorder and schizophrenia. Psychological Medicine. 43: 109-17. PMID 22583955 DOI: 10.1017/S0033291712001006  0.141
2017 Dunn W, Wynn JK, Rassovsky Y, Wu A, Iacoboni M, Hellemann G, Green MF. 431. The Effect of Bilateral Transcranial Direct Current Stimulation on Tone Matching Task Performance and Mismatch Negativity in Schizophrenia Biological Psychiatry. 81: S176. DOI: 10.1016/j.biopsych.2017.02.915  0.141
1987 Green MF, Satz P, Soper HV, Kharabi F. Relationship between physical anomalies and age at onset of schizophrenia. The American Journal of Psychiatry. 144: 666-7. PMID 3578581 DOI: 10.1176/ajp.144.5.666  0.141
2018 Reddy LF, Reavis EA, Wynn JK, Green MF. Pupillary responses to a cognitive effort task in schizophrenia. Schizophrenia Research. PMID 29526458 DOI: 10.1016/J.Schres.2018.03.005  0.141
2017 Dunn W, Wynn JK, Rassovsky Y, Wu A, Iacoboni M, Hellemann G, Green MF. SU103. The Effect of Bilateral Transcranial Direct Current Stimulation on Tone Matching Task Performance and Mismatch Negativity in Schizophrenia Schizophrenia Bulletin. 43: S198-S198. DOI: 10.1016/J.Biopsych.2017.02.915  0.141
2011 Mancuso F, Horan WP, Kern RS, Green MF. Social cognition in psychosis: multidimensional structure, clinical correlates, and relationship with functional outcome. Schizophrenia Research. 125: 143-51. PMID 21112743 DOI: 10.1016/J.Schres.2010.11.007  0.141
2013 Breitmeyer BG, Jahshan C, Wynn JK, Green MF. Response to Vakalopoulos' letter to the editor Re: Nonconscious and conscious color priming in schizophrenia. Journal of Psychiatric Research. 47: 138-9. PMID 23157801 DOI: 10.1016/J.Jpsychires.2012.09.022  0.141
1988 Green MF, Nuechterlein KH. Neuroleptic effects on electrodermal responsivity to soft tones and loud noise in schizophrenia. Psychiatry Research. 24: 79-86. PMID 2899332 DOI: 10.1016/0165-1781(88)90143-6  0.141
2007 Bellack AS, Green MF, Cook JA, Fenton W, Harvey PD, Heaton RK, Laughren T, Leon AC, Mayo DJ, Patrick DL, Patterson TL, Rose A, Stover E, Wykes T. Assessment of community functioning in people with schizophrenia and other severe mental illnesses: a white paper based on an NIMH-sponsored workshop. Schizophrenia Bulletin. 33: 805-22. PMID 16931542 DOI: 10.1093/Schbul/Sbl035  0.141
2017 Green MF, Horan WP, Lee J, McCleery A, Reddy LF, Wynn JK. At Issue: Social Disconnection in Schizophrenia and the General Community. Schizophrenia Bulletin. PMID 28637195 DOI: 10.1093/Schbul/Sbx082  0.141
1989 Green MF, Nuechterlein KH, Satz P. The relationship of symptomatology and medication to electrodermal activity in schizophrenia. Psychophysiology. 26: 148-57. PMID 2567035 DOI: 10.1111/J.1469-8986.1989.Tb03147.X  0.141
2020 Jimenez AM, Lee J, Reavis EA, Wynn JK, Green MF. Neural Correlates of Subjective Recollection of Socially Relevant Information in Schizophrenia Biological Psychiatry. 87: S419. DOI: 10.1016/J.Biopsych.2020.02.1070  0.14
1993 Green M, Hugdahl K, Mitchell S, Gutkind D, Christenson C. Dichotic listening during auditory hallucinations in schizophrenia Schizophrenia Research. 9: 176-177. DOI: 10.1016/0920-9964(93)90345-J  0.14
2016 Reddy LF, Waltz JA, Green MF, Wynn JK, Horan WP. Probabilistic Reversal Learning in Schizophrenia: Stability of Deficits and Potential Causal Mechanisms. Schizophrenia Bulletin. PMID 26884546 DOI: 10.1093/Schbul/Sbv226  0.14
1997 Green MF, Nuechterlein KH, Breitmeyer B. Backward masking performance in unaffected siblings of schizophrenic patients. Evidence for a vulnerability indicator. Archives of General Psychiatry. 54: 465-72. PMID 9152100 DOI: 10.1001/Archpsyc.1997.01830170091012  0.14
1997 Ames D, Wirshing WC, Marshall BD, Green MF, McGurk SR, Mintz J, Marder SR. Risperidone vs. Haloperidol in treatment resistant schizophrenia Schizophrenia Research. 24: 193-194. DOI: 10.1016/S0920-9964(97)82554-6  0.14
1997 Wirshing W, Green M, Ames D, Marshall B, McGurk S, Mintz J, Marder S. Risperidone vs. haloperidol in treatment-resistant schizophrenia Biological Psychiatry. 42: 177S-178S. DOI: 10.1016/S0006-3223(97)87635-4  0.14
2016 Lee J, Horan WP, Wynn JK, Green MF. Neural Correlates of Belief and Emotion Attribution in Schizophrenia. Plos One. 11: e0165546. PMID 27812142 DOI: 10.1371/Journal.Pone.0165546  0.139
2006 Horan WP, Green MF, Kring AM, Nuechterlein KH. Does anhedonia in schizophrenia reflect faulty memory for subjectively experienced emotions? Journal of Abnormal Psychology. 115: 496-508. PMID 16866590 DOI: 10.1037/0021-843X.115.3.496  0.139
2014 Davis MC, Green MF, Lee J, Horan WP, Senturk D, Clarke AD, Marder SR. Oxytocin-augmented social cognitive skills training in schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 2070-7. PMID 24637803 DOI: 10.1038/Npp.2014.68  0.139
2004 Altshuler LL, Ventura J, van Gorp WG, Green MF, Theberge DC, Mintz J. Neurocognitive function in clinically stable men with bipolar I disorder or schizophrenia and normal control subjects. Biological Psychiatry. 56: 560-9. PMID 15476685 DOI: 10.1016/J.Biopsych.2004.08.002  0.139
2003 Brekke J, Kay D, Kee K, Green M. Biosocial pathways to functional outcome in schizophrenia: A path analytic model Schizophrenia Research. 60: 166. DOI: 10.1016/S0920-9964(03)81024-1  0.139
2005 Nguyen AT, Subotnik KL, Green MF, Nuechterlein KH, Ventura J, Horan W, Mintz J. 96 FORMAL THOUGHT DISORDER AND MEMORY IMPAIRMENT IN SCHIZOPHRENIA Journal of Investigative Medicine. 53: S94.3-S94. DOI: 10.2310/6650.2005.00005.95  0.138
2003 Rassovsky Y, Green M, Nuechterlein K, Breitmeyer B, Mintz J. Assessing visual masking in schizophrenia with the paracontrast and metacontrast procedures Schizophrenia Research. 60: 154. DOI: 10.1016/S0920-9964(03)80985-4  0.138
1997 Wexler BE, Hawkins KA, Rounsaville B, Anderson M, Sernyak MJ, Green MF. Normal neurocognitive performance after extended practice in patients with schizophrenia. Schizophrenia Research. 26: 173-80. PMID 9323348 DOI: 10.1016/S0920-9964(97)00053-4  0.138
2018 Wynn JK, Green MF, Hellemann G, Reavis EA, Marder SR. A dose-finding study of oxytocin using neurophysiological measures of social processing. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 30082892 DOI: 10.1038/S41386-018-0165-Y  0.138
2020 Reed AC, Lee J, Green MF, Hamilton HK, Miller GA, Subotnik KL, Ventura J, Nuechterlein KH, Yee CM. Associations between physiological responses to social-evaluative stress and daily functioning in first-episode schizophrenia. Schizophrenia Research. PMID 31948901 DOI: 10.1016/J.Schres.2019.12.040  0.137
1997 Wyatt RJ, Green MF, Tuma AH. Long-term morbidity associated with delayed treatment of first admission schizophrenic patients: a re-analysis of the Camarillo State Hospital data. Psychological Medicine. 27: 261-8. PMID 9089819 DOI: 10.1017/S0033291796004345  0.137
2014 Light G, Greenwood TA, Swerdlow NR, Calkins ME, Freedman R, Green MF, Gur RE, Gur RC, Lazzeroni LC, Nuechterlein KH, Olincy A, Radant AD, Seidman LJ, Siever LJ, Silverman JM, et al. Comparison of the heritability of schizophrenia and endophenotypes in the COGS-1 family study. Schizophrenia Bulletin. 40: 1404-11. PMID 24903414 DOI: 10.1093/Schbul/Sbu064  0.136
1999 Green MF, Nuechterlein KH. Cortical oscillations and schizophrenia: timing is of the essence. Archives of General Psychiatry. 56: 1007-8. PMID 10565500 DOI: 10.1001/Archpsyc.56.11.1007  0.136
2019 Wynn JK, Engel SA, Lee J, Reavis EA, Green MF. Evidence for intact stimulus-specific neural adaptation for visual objects in schizophrenia and bipolar disorder: An ERP study. Plos One. 14: e0221409. PMID 31430347 DOI: 10.1371/Journal.Pone.0221409  0.136
2019 Yang YS, Davis MC, Wynn JK, Hellemann G, Green MF, Marder SR. N-acetylcysteine improves EEG measures of auditory deviance detection and neural synchronization in schizophrenia: A randomized, controlled pilot study. Schizophrenia Research. PMID 30712814 DOI: 10.1016/J.Schres.2019.01.036  0.134
2019 Lee J, Reavis E, Wein R, Tucker Z, Humble J, Green MF. T78. NEURAL CORRELATES OF SOCIAL ATTENTION IN SCHIZOPHRENIA Schizophrenia Bulletin. 45: S234-S234. DOI: 10.1093/Schbul/Sbz019.358  0.134
2017 Reddy LF, Horan WP, Barch DM, Buchanan RW, Gold JM, Marder SR, Wynn JK, Young J, Green MF. Understanding the Association Between Negative Symptoms and Performance on Effort-Based Decision-Making Tasks: The Importance of Defeatist Performance Beliefs. Schizophrenia Bulletin. PMID 29140501 DOI: 10.1093/Schbul/Sbx156  0.134
2010 Horan WP, Wynn JK, Kring AM, Simons RF, Green MF. Electrophysiological correlates of emotional responding in schizophrenia. Journal of Abnormal Psychology. 119: 18-30. PMID 20141239 DOI: 10.1037/A0017510  0.134
2017 Jahshan C, Wynn JK, Mathalon DH, Green MF. Cognitive correlates of visual neural plasticity in schizophrenia. Schizophrenia Research. PMID 28336195 DOI: 10.1016/J.Schres.2017.03.016  0.134
2023 Bao Y, Qiao Y, Choi JE, Zhang Y, Mannan R, Cheng C, He T, Zheng Y, Yu J, Gondal M, Cruz G, Grove S, Cao X, Su F, Wang R, ... ... Green MD, et al. Targeting the lipid kinase PIKfyve upregulates surface expression of MHC class I to augment cancer immunotherapy. Proceedings of the National Academy of Sciences of the United States of America. 120: e2314416120. PMID 38011559 DOI: 10.1073/pnas.2314416120  0.134
2018 Lee J, Jimenez AM, Reavis EA, Horan WP, Wynn JK, Green MF. Reduced Neural Sensitivity to Social vs Nonsocial Reward in Schizophrenia. Schizophrenia Bulletin. PMID 30189096 DOI: 10.1093/Schbul/Sby109  0.133
2009 Barch DM, Carter CS, Arnsten A, Buchanan RW, Cohen JD, Geyer M, Green MF, Krystal JH, Nuechterlein K, Robbins T, Silverstein S, Smith EE, Strauss M, Wykes T, Heinssen R. Selecting paradigms from cognitive neuroscience for translation into use in clinical trials: proceedings of the third CNTRICS meeting. Schizophrenia Bulletin. 35: 109-14. PMID 19023126 DOI: 10.1093/Schbul/Sbn163  0.133
2017 Dunn W, Rassovsky Y, Wynn J, Wu AD, Iacoboni M, Hellemann G, Green MF. The effect of bilateral transcranial direct current stimulation on early auditory processing in schizophrenia: a preliminary study. Journal of Neural Transmission (Vienna, Austria : 1996). PMID 28687908 DOI: 10.1007/S00702-017-1752-5  0.132
2015 Green MR, Kihira S, Liu CL, Nair RV, Salari R, Gentles AJ, Irish J, Stehr H, Vicente-Dueñas C, Romero-Camarero I, Sanchez-Garcia I, Plevritis SK, Arber DA, Batzoglou S, Levy R, et al. Mutations in early follicular lymphoma progenitors are associated with suppressed antigen presentation. Proceedings of the National Academy of Sciences of the United States of America. 112: E1116-25. PMID 25713363 DOI: 10.1073/Pnas.1501199112  0.132
2007 Sergi MJ, Green MF, Widmark C, Reist C, Erhart S, Braff DL, Kee KS, Marder SR, Mintz J. Social cognition [corrected] and neurocognition: effects of risperidone, olanzapine, and haloperidol. The American Journal of Psychiatry. 164: 1585-92. PMID 17898351 DOI: 10.1176/Appi.Ajp.2007.06091515  0.132
1998 Kee KS, Kern RS, Marshall BD, Green MF. Risperidone versus haloperidol for perception of emotion in treatment-resistant schizophrenia: preliminary findings. Schizophrenia Research. 31: 159-65. PMID 9689720 DOI: 10.1016/S0920-9964(98)00026-7  0.131
2020 Green MF, Lee J, Wynn JK. Experimental approaches to social disconnection in the general community: can we learn from schizophrenia research? World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 19: 177-178. PMID 32394575 DOI: 10.1002/Wps.20734  0.13
1998 Kern RS, Green MF, Marshall BD, Wirshing WC, Wirshing D, McGurk S, Marder SR, Mintz J. Risperidone vs. haloperidol on reaction time, manual dexterity, and motor learning in treatment-resistant schizophrenia patients. Biological Psychiatry. 44: 726-32. PMID 9798076 DOI: 10.1016/S0006-3223(98)00088-2  0.13
2000 Gilbert EA, Liberman RP, Ventura J, Kern R, Robertson MJ, Hwang S, Green MF. Concurrent validity of negative symptom assessments in treatment refractory schizophrenia: relationship between interview-based ratings and inpatient ward observations. Journal of Psychiatric Research. 34: 443-7. PMID 11165312 DOI: 10.1016/S0022-3956(00)00041-8  0.129
2002 Kern R, Cornblatt B, Carson W, Stock E, Saha A, Ali M, Ingenito G, Green M. Neurocognitive effects: aripiprazole vs olanzapine in stable psychosis European Psychiatry. 17: 104. DOI: 10.1016/S0924-9338(02)80470-9  0.128
1997 Toomey R, Wallace CJ, Corrigan PW, Schuldberg D, Green MF. Social processing correlates of nonverbal social perception in schizophrenia. Psychiatry. 60: 292-300. PMID 9460098 DOI: 10.1080/00332747.1997.11024807  0.128
2009 Brekke JS, Hoe M, Green MF. Neurocognitive change, functional change and service intensity during community-based psychosocial rehabilitation for schizophrenia. Psychological Medicine. 39: 1637-47. PMID 19243648 DOI: 10.1017/S003329170900539X  0.128
2014 Pinkham AE, Penn DL, Green MF, Buck B, Healey K, Harvey PD. The social cognition psychometric evaluation study: results of the expert survey and RAND panel. Schizophrenia Bulletin. 40: 813-23. PMID 23728248 DOI: 10.1093/Schbul/Sbt081  0.128
2011 Horan WP, Kern RS, Tripp C, Hellemann G, Wynn JK, Bell M, Marder SR, Green MF. Efficacy and specificity of social cognitive skills training for outpatients with psychotic disorders. Journal of Psychiatric Research. 45: 1113-22. PMID 21377168 DOI: 10.1016/J.Jpsychires.2011.01.015  0.128
2014 Rassovsky Y, Lee J, Nori P, Wu AD, Iacoboni M, Breitmeyer BG, Hellemann G, Green MF. Exploring facial emotion perception in schizophrenia using transcranial magnetic stimulation and spatial filtering. Journal of Psychiatric Research. 58: 102-8. PMID 25106071 DOI: 10.1016/J.Jpsychires.2014.07.017  0.127
2023 Chu F, Cao J, Liu J, Yang H, Davis TJ, Kuang SQ, Cheng X, Zhang Z, Karri S, Vien LT, Bover L, Sun R, Vega F, Green M, Davis RE, et al. Chimeric antigen receptor T cells to target CD79b in B-cell lymphomas. Journal For Immunotherapy of Cancer. 11. PMID 38007239 DOI: 10.1136/jitc-2023-007515  0.127
2019 Lee J, Jimenez AM, Horan WP, Green MF. fMRI biomarkers of social cognitive skills training in psychosis: Extrinsic and intrinsic functional connectivity. Plos One. 14: e0214303. PMID 31100068 DOI: 10.1371/Journal.Pone.0214303  0.127
2002 Green MF, Nuechterlein KH, Breitmeyer B. Development of a computerized assessment for visual masking. International Journal of Methods in Psychiatric Research. 11: 83-9. PMID 12459798 DOI: 10.1002/Mpr.126  0.127
1995 Subotnik KI, Bartzokis G, Nuechterlein KH, Green MF, Ventura J. Hippocampal volume, verbal working memory, and thought disorder in schizophrenia: A pilot study Schizophrenia Research. 15: 135-136. DOI: 10.1016/0920-9964(95)95421-5  0.127
2006 Kee KS, Horan WP, Wynn JK, Mintz J, Green MF. An analysis of categorical perception of facial emotion in schizophrenia. Schizophrenia Research. 87: 228-37. PMID 16859896 DOI: 10.1016/J.Schres.2006.06.001  0.127
2017 Reavis E, Lee J, Wynn J, Engel S, Cohen M, Nuechterlein K, Glahn D, Hoy J, Polon N, Green M. 82. Assessing Fidelity of Object Representations in Visual Cortex in Schizophrenia and Bipolar Disorder Using Multivariate Pattern Analysis Schizophrenia Bulletin. 43: S46-S46. DOI: 10.1093/Schbul/Sbx021.121  0.126
2019 McCleery A, Mathalon DH, Wynn JK, Roach BJ, Hellemann GS, Marder SR, Green MF. Parsing components of auditory predictive coding in schizophrenia using a roving standard mismatch negativity paradigm. Psychological Medicine. 1-12. PMID 30642411 DOI: 10.1017/S0033291718004087  0.126
2003 Subotnik KL, Bartzokis G, Green MF, Nuechterlein KH. Neuroanatomical correlates of formal thought disorder in schizophrenia. Cognitive Neuropsychiatry. 8: 81-8. PMID 16571552 DOI: 10.1080/13546800244000148  0.126
2002 Kern RS, Liberman RP, Kopelowicz A, Mintz J, Green MF. Applications of errorless learning for improving work performance in persons with schizophrenia. The American Journal of Psychiatry. 159: 1921-6. PMID 12411229 DOI: 10.1176/Appi.Ajp.159.11.1921  0.125
2005 Kern RS, Green MF, Mitchell S, Kopelowicz A, Mintz J, Liberman RP. Extensions of errorless learning for social problem-solving deficits in schizophrenia. The American Journal of Psychiatry. 162: 513-9. PMID 15741468 DOI: 10.1176/Appi.Ajp.162.3.513  0.125
2018 Jimenez AM, Lee J, Reavis EA, Wynn JK, Green MF. Aberrant patterns of neural activity when perceiving emotion from biological motion in schizophrenia. Neuroimage. Clinical. 20: 380-387. PMID 30128276 DOI: 10.1016/J.Nicl.2018.08.014  0.125
2019 Horan WP, Wynn JK, Gabrielian S, Glynn SM, Hellemann GS, Kern RS, Lee J, Marder SR, Sugar CA, Green MF. Motivational and cognitive correlates of community integration in homeless veterans entering a permanent supported housing program. The American Journal of Orthopsychiatry. PMID 31021133 DOI: 10.1037/Ort0000420  0.124
2011 Bearden CE, Shih VH, Green MF, Gitlin M, Sokolski KN, Levander E, Marusak S, Hammen C, Sugar CA, Altshuler LL. The impact of neurocognitive impairment on occupational recovery of clinically stable patients with bipolar disorder: a prospective study. Bipolar Disorders. 13: 323-33. PMID 21843272 DOI: 10.1111/J.1399-5618.2011.00928.X  0.124
2024 Fisher BT, Blumenstock J, Boge CLK, Shuster S, Seif AE, Green M, Michaels MG, Alexander JL, Ardura MI, Miller TP, Hijano DR, Muller WJ, Schuster JE, Green AM, Dulek DE, et al. Approach for defining human adenovirus infection and disease for central review adjudication in clinical studies. Pediatric Transplantation. 28: e14750. PMID 38623880 DOI: 10.1111/petr.14750  0.124
2023 Tandon R, Nasrallah H, Akbarian S, Carpenter WT, DeLisi LE, Gaebel W, Green MF, Gur RE, Heckers S, Kane JM, Malaspina D, Meyer-Lindenberg A, Murray R, Owen M, Smoller JW, et al. The schizophrenia syndrome, circa 2024: What we know and how that informs its nature. Schizophrenia Research. 264: 1-28. PMID 38086109 DOI: 10.1016/j.schres.2023.11.015  0.124
1997 Green MF, Marshall BD, Wirshing WC, Ames D, Marder SR, McGurk S, Kern RS, Mintz J. Does risperidone improve verbal working memory in treatment-resistant schizophrenia? The American Journal of Psychiatry. 154: 799-804. PMID 9167507 DOI: 10.1176/Ajp.154.6.799  0.123
2005 Rassovsky Y, Green MF, Nuechterlein KH, Breitmeyer BG, Mintz J. Visual processing in schizophrenia: Structural equation modeling of visual masking performance. Schizophrenia Research. 78: 251-60. PMID 15975768 DOI: 10.1016/J.Schres.2005.05.011  0.123
2017 Horan WP, Dolinsky M, Lee J, Kern RS, Hellemann G, Sugar CA, Glynn SM, Green MF. Social Cognitive Skills Training for Psychosis With Community-Based Training Exercises: A Randomized Controlled Trial. Schizophrenia Bulletin. PMID 29300973 DOI: 10.1093/Schbul/Sbx167  0.123
2015 Greenwood TA, Light GA, Swerdlow NR, Calkins ME, Green MF, Gur RE, Gur RC, Lazzeroni LC, Nuechterlein KH, Olincy A, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Stone WS, et al. Gating Deficit Heritability and Correlation With Increased Clinical Severity in Schizophrenia Patients With Positive Family History. The American Journal of Psychiatry. appiajp201515050605. PMID 26441157 DOI: 10.1176/Appi.Ajp.2015.15050605  0.123
1997 Kern RS, Green MF, Wallace CJ. Declarative and procedural learning in schizophrenia: a test of the integrity of divergent memory systems. Cognitive Neuropsychiatry. 2: 39-50. PMID 25420138 DOI: 10.1080/135468097396405  0.123
1994 Green MF, Hugdahl K, Mitchell S. Dichotic listening during auditory hallucinations in patients with schizophrenia. The American Journal of Psychiatry. 151: 357-62. PMID 8109643 DOI: 10.1176/ajp.151.3.357  0.122
2014 Green MR, Vicente-Dueñas C, Alizadeh AA, Sánchez-García I. Hit-and-run lymphomagenesis by the Bcl6 oncogene. Cell Cycle (Georgetown, Tex.). 13: 1831-2. PMID 24867153 DOI: 10.4161/Cc.29326  0.122
1995 Kern RS, Green MF, Goldstein MJ. Modification of performance on the span of apprehension, a putative marker of vulnerability to schizophrenia. Journal of Abnormal Psychology. 104: 385-9. PMID 7790641 DOI: 10.1037//0021-843X.104.2.385  0.122
2005 McGurk SR, Carter C, Goldman R, Green MF, Marder SR, Xie H, Schooler NR, Kane JM. The effects of clozapine and risperidone on spatial working memory in schizophrenia. The American Journal of Psychiatry. 162: 1013-6. PMID 15863811 DOI: 10.1176/Appi.Ajp.162.5.1013  0.12
2014 Jahshan C, Wynn JK, McCleery A, Glahn DC, Altshuler LL, Green MF. Cross-diagnostic comparison of visual processing in bipolar disorder and schizophrenia. Journal of Psychiatric Research. 51: 42-8. PMID 24433849 DOI: 10.1016/J.Jpsychires.2013.12.014  0.12
2023 Li X, Henderson J, Gordon MJ, Sheikh I, Nastoupil LJ, Westin J, Flowers C, Ahmed S, Wang L, Neelapu SS, Strati P, Deng Q, Green MR. A single-cell atlas of CD19 chimeric antigen receptor T cells. Cancer Cell. PMID 37738975 DOI: 10.1016/j.ccell.2023.08.015  0.12
2019 Crowshoe LL, Henderson R, Jacklin K, Calam B, Walker L, Green ME. Canadian Family Physician Medecin De Famille Canadien. 65: e19-e29. PMID 30674525  0.12
2020 Wharton S, Lau DCW, Vallis M, Sharma AM, Biertho L, Campbell-Scherer D, Adamo K, Alberga A, Bell R, Boulé N, Boyling E, Brown J, Calam B, Clarke C, Crowshoe L, ... ... Green M, et al. Cmaj : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne. 192: E1757-E1775. PMID 33288515 DOI: 10.1503/cmaj.191707-f  0.12
2023 Gourisankar S, Krokhotin A, Ji W, Liu X, Chang CY, Kim SH, Li Z, Wenderski W, Simanauskaite JM, Yang H, Vogel H, Zhang T, Green MR, Gray NS, Crabtree GR. Rewiring cancer drivers to activate apoptosis. Nature. PMID 37495688 DOI: 10.1038/s41586-023-06348-2  0.12
2024 Isenor JE, Renaud L, Mathews M, Morrison B, Murphy AL, Bishop A, Bowles SK, Kennie-Kaulbach N, Peddle S, Breton M, Green ME, Marshall EG. Patient perspectives on the vital primary care role of community pharmacists in Nova Scotia, Canada: qualitative findings from the PUPPY Study. The International Journal of Pharmacy Practice. PMID 38484181 DOI: 10.1093/ijpp/riae008  0.12
2017 Grazioplene R, Bearden C, Subotnik K, Ventura J, Green MF, Nuechterlein K, Cannon T. 85. Diffusion Imaging of White Matter Pathways in Schizophrenia: Are Illness-Linked Changes Progressive? Schizophrenia Bulletin. 43: S47-S47. DOI: 10.1093/Schbul/Sbx021.124  0.119
2003 Kern R, Green M, Kopelowicz A, Mitchell S, Herrera A, Kogler K, Doran D, Liberman R. An innovative compensatory intervention for rehabilitation in schizophrenia: The effects of errorless learning on work training outcome Schizophrenia Research. 60: 172. DOI: 10.1016/S0920-9964(03)81045-9  0.119
2016 Horan WP, Jimenez AM, Lee J, Wynn JK, Eisenberger NI, Green MF. Pain Empathy in Schizophrenia: An fMRI Study. Social Cognitive and Affective Neuroscience. PMID 26746181 DOI: 10.1093/Scan/Nsw002  0.119
2015 McCormack C, Green MJ, Rowland JE, Roberts G, Frankland A, Hadzi-Pavlovic D, Joslyn C, Lau P, Wright A, Levy F, Lenroot RK, Mitchell PB. Neuropsychological and social cognitive function in young people at genetic risk of bipolar disorder. Psychological Medicine. 1-14. PMID 26621494 DOI: 10.1017/S0033291715002147  0.119
1991 Corrigan PW, Green MF. Signal detection analysis of short-term recall in schizophrenia. The Journal of Nervous and Mental Disease. 179: 495-8. PMID 1856713 DOI: 10.1097/00005053-199108000-00008  0.119
2024 Plotnik JP, Richardson AE, Yang H, Rojas E, Bontcheva V, Dowell C, Parsons S, Wilson A, Ravanmehr V, Will C, Jung P, Zhu H, Partha SK, Panchal SC, Mali RS, ... ... Green MR, et al. Inhibition of MALT1 and BCL2 induces synergistic anti-tumor activity in models of B cell lymphoma. Molecular Cancer Therapeutics. PMID 38507740 DOI: 10.1158/1535-7163.MCT-23-0518  0.118
2017 Wynn J, McCleery A, Szewczyk W, Kutasevich E, Roach BJ, Mathalon D, Green MF. SA68. Dysfunctional Prediction Error Coding in Schizophrenia: Test–Retest Reliability of Auditory Mismatch Negativity and Repetition Positivity Schizophrenia Bulletin. 43: S137-S138. DOI: 10.1093/Schbul/Sbx023.067  0.118
1999 Løberg EM, Hugdahl K, Green MF. Hemispheric asymmetry in schizophrenia: a "dual deficits" model. Biological Psychiatry. 45: 76-81. PMID 9894578 DOI: 10.1016/S0006-3223(98)00219-4  0.117
2017 Hellemann GS, Green MF, Kern RS, Sitarenios G, Nuechterlein KH. Developing an international scoring system for a consensus-based social cognition measure: MSCEIT-managing emotions. Psychological Medicine. 1-8. PMID 28443534 DOI: 10.1017/S0033291717001052  0.117
2004 Ventura J, Nuechterlein KH, Green MF, Horan WP, Subotnik KL, Mintz J. The timing of negative symptom exacerbations in relationship to positive symptom exacerbations in the early course of schizophrenia. Schizophrenia Research. 69: 333-42. PMID 15469205 DOI: 10.1016/S0920-9964(03)00096-3  0.117
2015 Hudson CD, Bradley AJ, Breen JE, Green MJ. Dairy herd mastitis and reproduction: using simulation to aid interpretation of results from discrete time survival analysis. Veterinary Journal (London, England : 1997). 204: 47-53. PMID 25744810 DOI: 10.1016/j.tvjl.2015.01.024  0.116
1999 Kern RS, Green MF, Marshall BD, Wirshing WC, Wirshing D, McGurk SR, Marder SR, Mintz J. Risperidone versus haloperidol on secondary memory: can newer medications aid learning? Schizophrenia Bulletin. 25: 223-32. PMID 10416728 DOI: 10.1093/Oxfordjournals.Schbul.A033375  0.116
2020 Kantrowitz JT, Grinband J, Goff DC, Lahti AC, Marder SR, Kegeles LS, Girgis RR, Sobeih T, Wall MM, Choo TH, Green MF, Yang YS, Lee J, Horga G, Krystal JH, et al. Proof of mechanism and target engagement of glutamatergic drugs for the treatment of schizophrenia: RCTs of pomaglumetad and TS-134 on ketamine-induced psychotic symptoms and pharmacoBOLD in healthy volunteers. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 32403118 DOI: 10.1038/S41386-020-0706-Z  0.116
2008 Horan WP, Green MF, Knowlton BJ, Wynn JK, Mintz J, Nuechterlein KH. Impaired implicit learning in schizophrenia. Neuropsychology. 22: 606-17. PMID 18763880 DOI: 10.1037/A0012602  0.116
2008 Altshuler LL, Bearden CE, Green MF, van Gorp W, Mintz J. A relationship between neurocognitive impairment and functional impairment in bipolar disorder: a pilot study. Psychiatry Research. 157: 289-93. PMID 17868903 DOI: 10.1016/J.Psychres.2007.01.001  0.115
1993 Corrigan PW, Green MF. Schizophrenic patients' sensitivity to social cues: the role of abstraction. The American Journal of Psychiatry. 150: 589-94. PMID 8465875 DOI: 10.1176/Ajp.150.4.589  0.115
2023 Strati P, Li X, Deng Q, Marques-Piubelli ML, Henderson J, Watson G, Deaton L, Cain T, Yang H, Ravanmehr V, Fayad LE, Iyer SP, Nastoupil LJ, Hagemeister FB, Parra ER, ... ... Green MR, et al. Prolonged cytopenia following CD19 CAR T cell therapy is linked with bone marrow infiltration of clonally expanded IFNγ-expressing CD8 T cells. Cell Reports. Medicine. 4: 101158. PMID 37586321 DOI: 10.1016/j.xcrm.2023.101158  0.115
2015 Heide J, Zhang F, Bigos KL, Mann SA, Carr VJ, Shannon Weickert C, Green MJ, Weinberger DR, Vandenberg JI. Differential Response to Risperidone in Schizophrenia Patients by KCNH2 Genotype and Drug Metabolizer Status. The American Journal of Psychiatry. appiajp201514050653. PMID 26481172 DOI: 10.1176/Appi.Ajp.2015.14050653  0.115
2021 Maj M, van Os J, De Hert M, Gaebel W, Galderisi S, Green MF, Guloksuz S, Harvey PD, Jones PB, Malaspina D, McGorry P, Miettunen J, Murray RM, Nuechterlein KH, Peralta V, et al. The clinical characterization of the patient with primary psychosis aimed at personalization of management. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 20: 4-33. PMID 33432763 DOI: 10.1002/wps.20809  0.115
2015 Breakspear M, Roberts G, Green MJ, Nguyen VT, Frankland A, Levy F, Lenroot R, Mitchell PB. Network dysfunction of emotional and cognitive processes in those at genetic risk of bipolar disorder. Brain : a Journal of Neurology. PMID 26373604 DOI: 10.1093/Brain/Awv261  0.113
2022 Cherng HJ, Sun R, Sugg B, Irwin R, Yang H, Le CC, Deng Q, Fayad LE, Fowler NH, Parmar S, Steiner RE, Hagemeister FB, Nair R, Lee HJ, Rodriguez MA, ... ... Green MR, et al. Risk assessment with low pass whole genome sequencing of cell free DNA before CD19 CAR T-cells for large B-cell lymphoma. Blood. PMID 35512184 DOI: 10.1182/blood.2022015601  0.113
2015 Jarskog LF, Lowy MT, Grove RA, Keefe RS, Horrigan JP, Ball MP, Breier A, Buchanan RW, Carter CS, Csernansky JG, Goff DC, Green MF, Kantrowitz JT, Keshavan MS, Laurelle M, et al. A Phase II study of a histamine H₃ receptor antagonist GSK239512 for cognitive impairment in stable schizophrenia subjects on antipsychotic therapy. Schizophrenia Research. 164: 136-42. PMID 25728831 DOI: 10.1016/J.Schres.2015.01.041  0.113
2015 Kurtz DM, Green MR, Bratman SV, Scherer F, Liu CL, Kunder CA, Takahashi K, Glover C, Keane C, Kihira S, Visser B, Callahan J, Kong KA, Faham M, Corbelli KS, et al. Noninvasive monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencing. Blood. 125: 3679-87. PMID 25887775 DOI: 10.1182/Blood-2015-03-635169  0.112
2002 Bueno J, Ramil C, Green M. Current management strategies for the prevention and treatment of cytomegalovirus infection in pediatric transplant recipients Pediatric Drugs. 4: 279-290. PMID 11994033  0.112
2024 Choi JE, Qiao Y, Kryczek I, Yu J, Gurkan J, Bao Y, Gondal M, Tien JC, Maj T, Yazdani S, Parolia A, Xia H, Zhou J, Wei S, Grove S, ... ... Green MD, et al. PIKfyve controls dendritic cell function and tumor immunity. Biorxiv : the Preprint Server For Biology. PMID 38464258 DOI: 10.1101/2024.02.28.582543  0.112
2013 Pistis G, Okonkwo SU, Traglia M, Sala C, Shin SY, Masciullo C, Buetti I, Massacane R, Mangino M, Thein SL, Spector TD, Ganesh S, Pirastu N, Gasparini P, ... ... Green MR, et al. Genome wide association analysis of a founder population identified TAF3 as a gene for MCHC in humans. Plos One. 8: e69206. PMID 23935956 DOI: 10.1371/Journal.Pone.0069206  0.111
2012 Horan WP, Foti D, Hajcak G, Wynn JK, Green MF. Intact motivated attention in schizophrenia: evidence from event-related potentials. Schizophrenia Research. 135: 95-9. PMID 22126898 DOI: 10.1016/J.Schres.2011.11.005  0.11
1993 Green MF, Mintz J, Bowen L, Marshall BD, Kuehnel TG, Hayden JL, Liberman RP. Prediction of response to haloperidol dose reduction by Span of Apprehension measures for treatment-refractory schizophrenic patients. The American Journal of Psychiatry. 150: 1415-6. PMID 8352355 DOI: 10.1176/Ajp.150.9.1415  0.11
2015 Nuechterlein KH, Green MF, Calkins ME, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Light GA, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Sprock J, Stone WS, Sugar CA, et al. Attention/vigilance in schizophrenia: performance results from a large multi-site study of the Consortium on the Genetics of Schizophrenia (COGS). Schizophrenia Research. 163: 38-46. PMID 25749017 DOI: 10.1016/J.Schres.2015.01.017  0.11
2005 Sergi MJ, Kern RS, Mintz J, Green MF. Learning potential and the prediction of work skill acquisition in schizophrenia. Schizophrenia Bulletin. 31: 67-72. PMID 15888426 DOI: 10.1093/Schbul/Sbi007  0.11
2003 Kee KS, Green MF, Mintz J, Brekke JS. Is emotion processing a predictor of functional outcome in schizophrenia? Schizophrenia Bulletin. 29: 487-97. PMID 14609242 DOI: 10.1093/Oxfordjournals.Schbul.A007021  0.109
2024 Deng Q, Lakra P, Gou P, Yang H, Meydan C, Teater M, Chin C, Zhang W, Dinh T, Hussein U, Li X, Rojas E, Liu W, Reville PK, Kizhakeyil A, ... ... Green MR, et al. SMARCA4 is a haploinsufficient B cell lymphoma tumor suppressor that fine-tunes centrocyte cell fate decisions. Cancer Cell. PMID 38458188 DOI: 10.1016/j.ccell.2024.02.011  0.109
2017 Jimenez A, Lee J, Wynn JK, Horan W, Iglesias J, Hoy J, Green MF. 56. The Role of Prefrontal Cortex in Self-Referential Memory Retrieval in Schizophrenia Schizophrenia Bulletin. 43: S29-S29. DOI: 10.1093/Schbul/Sbx021.075  0.109
2020 Jahshan C, Wynn JK, Roach BJ, Mathalon DH, Green MF. Effects of Transcranial Direct Current Stimulation on Visual Neuroplasticity in Schizophrenia. Clinical Eeg and Neuroscience. 1550059420925697. PMID 32463701 DOI: 10.1177/1550059420925697  0.108
2024 Wang B, Reville PK, Yassouf MY, Jelloul FZ, Ly C, Desai PN, Wang Z, Borges P, Veletic I, Dasdemir E, Burks JK, Tang G, Guo S, Garza AI, Nasnas C, ... ... Green MR, et al. Comprehensive characterization of IFNγ signaling in acute myeloid leukemia reveals prognostic and therapeutic strategies. Nature Communications. 15: 1821. PMID 38418901 DOI: 10.1038/s41467-024-45916-6  0.108
1991 Kern RS, Green MF, Satz P, Wirshing WC. Patterns of manual dominance in patients with neuroleptic-induced movement disorders. Biological Psychiatry. 30: 483-92. PMID 1681944 DOI: 10.1016/0006-3223(91)90310-I  0.108
2022 Han G, Deng Q, Marques-Piubelli ML, Dai E, Dang M, Ma MCJ, Li X, Yang H, Henderson J, Kudryashova O, Meerson M, Isaev S, Kotlov N, Nomie KJ, Bagaev A, ... ... Green MR, et al. Follicular lymphoma microenvironment characteristics associated with tumor cell mutations and MHC class II expression. Blood Cancer Discovery. PMID 35687817 DOI: 10.1158/2643-3230.BCD-21-0075  0.108
2018 Lee J, Reavis EA, Engel SA, Altshuler LL, Cohen MS, Glahn DC, Nuechterlein KH, Wynn JK, Green MF. fMRI evidence of aberrant neural adaptation for objects in schizophrenia and bipolar disorder. Human Brain Mapping. PMID 30575206 DOI: 10.1002/Hbm.24472  0.108
2015 Bhatnagar S, Green MR. TRIMming down tumor suppressors in breast cancer. Cell Cycle (Georgetown, Tex.). 14: 1345-6. PMID 25790001 DOI: 10.1080/15384101.2015.1024584  0.108
2011 Ouyang J, Juszczynski P, Rodig SJ, Green MR, O'Donnell E, Currie T, Armant M, Takeyama K, Monti S, Rabinovich GA, Ritz J, Kutok JL, Shipp MA. Viral induction and targeted inhibition of galectin-1 in EBV+ posttransplant lymphoproliferative disorders. Blood. 117: 4315-22. PMID 21300977 DOI: 10.1182/Blood-2010-11-320481  0.107
1990 Green MF, Nuechterlein KH, Ventura J, Mintz J. The temporal relationship between depressive and psychotic symptoms in recent-onset schizophrenia. The American Journal of Psychiatry. 147: 179-82. PMID 2301655 DOI: 10.1176/Ajp.147.2.179  0.107
2020 Deng Q, Han G, Puebla-Osorio N, Ma MCJ, Strati P, Chasen B, Dai E, Dang M, Jain N, Yang H, Wang Y, Zhang S, Wang R, Chen R, Showell J, ... ... Green MR, et al. Characteristics of anti-CD19 CAR T cell infusion products associated with efficacy and toxicity in patients with large B cell lymphomas. Nature Medicine. PMID 33020644 DOI: 10.1038/s41591-020-1061-7  0.107
2014 Gray BE, McMahon RP, Green MF, Seidman LJ, Mesholam-Gately RI, Kern RS, Nuechterlein KH, Keefe RS, Gold JM. Detecting reliable cognitive change in individual patients with the MATRICS Consensus Cognitive Battery. Schizophrenia Research. 159: 182-7. PMID 25156338 DOI: 10.1016/J.Schres.2014.07.032  0.107
2004 Wiedl KH, Schöttke H, Green MF, Nuechterlein KH. Dynamic testing in schizophrenia: does training change the construct validity of a test? Schizophrenia Bulletin. 30: 703-11. PMID 15954185 DOI: 10.1093/Oxfordjournals.Schbul.A007124  0.106
2015 Brandt AL, Kelly AC, Green ML, Shelton P, Novakofski J, Mateus-Pinilla NE. Prion protein gene sequence and chronic wasting disease susceptibility in white-tailed deer (Odocoileus virginianus). Prion. 0. PMID 26634768 DOI: 10.1080/19336896.2015.1115179  0.106
2024 Barisic D, Chin CR, Meydan C, Teater M, Tsialta I, Mlynarczyk C, Chadburn A, Wang X, Sarkozy M, Xia M, Carson SE, Raggiri S, Debek S, Pelzer B, Durmaz C, ... ... Green MR, et al. ARID1A orchestrates SWI/SNF-mediated sequential binding of transcription factors with ARID1A loss driving pre-memory B cell fate and lymphomagenesis. Cancer Cell. PMID 38458187 DOI: 10.1016/j.ccell.2024.02.010  0.106
2006 Green MF, Nuechterlein KH, Breitmeyer B, Mintz J. Forward and backward visual masking in unaffected siblings of schizophrenic patients. Biological Psychiatry. 59: 446-51. PMID 16139818 DOI: 10.1016/J.Biopsych.2005.06.035  0.105
2002 Green MF, Marder SR, Glynn SM, McGurk SR, Wirshing WC, Wirshing DA, Liberman RP, Mintz J. The neurocognitive effects of low-dose haloperidol: a two-year comparison with risperidone. Biological Psychiatry. 51: 972-8. PMID 12062881 DOI: 10.1016/S0006-3223(02)01370-7  0.105
1992 Kern RS, Green MF, Satz P. Neuropsychological predictors of skills training for chronic psychiatric patients. Psychiatry Research. 43: 223-30. PMID 1359595 DOI: 10.1016/0165-1781(92)90055-8  0.105
2016 Jimenez AM, Lee J, Wynn JK, Cohen MS, Engel SA, Glahn DC, Nuechterlein KH, Reavis EA, Green MF. Abnormal Ventral and Dorsal Attention Network Activity during Single and Dual Target Detection in Schizophrenia. Frontiers in Psychology. 7: 323. PMID 27014135 DOI: 10.3389/Fpsyg.2016.00323  0.104
2009 Kern RS, Liberman RP, Becker DR, Drake RE, Sugar CA, Green MF. Errorless learning for training individuals with schizophrenia at a community mental health setting providing work experience. Schizophrenia Bulletin. 35: 807-15. PMID 18326529 DOI: 10.1093/Schbul/Sbn010  0.104
2023 Konopleva M, DiNardo C, Bhagat T, Baran N, Lodi A, Saxena K, Cai T, Su X, Skwarska A, Guerra V, Kuruvilla V, Konoplev S, Gordon-Mitchell S, Pradhan K, Aluri S, ... ... Green M, et al. Glutaminase inhibition in combination with azacytidine in myelodysplastic syndromes: Clinical efficacy and correlative analyses. Research Square. PMID 36865338 DOI: 10.21203/rs.3.rs-2518774/v1  0.104
2020 Wynn JK, Gabrielian S, Hellemann G, Horan WP, Kern RS, Lee J, Marder SR, Sugar CA, Green MF. Motivational and cognitive factors linked to community integration in homeless veterans: Study 2 - clinically diverse sample. Psychological Medicine. 1-8. PMID 32466807 DOI: 10.1017/S0033291720001609  0.104
2013 Jalbrzikowski M, Jonas R, Senturk D, Patel A, Chow C, Green MF, Bearden CE. Structural abnormalities in cortical volume, thickness, and surface area in 22q11.2 microdeletion syndrome: Relationship with psychotic symptoms. Neuroimage. Clinical. 3: 405-15. PMID 24273724 DOI: 10.1016/J.Nicl.2013.09.013  0.103
2015 Zhao LJ, Loewenstein PM, Green M. The adenovirus E1A oncoprotein N-terminal transcriptional repression domain enhances p300 autoacetylation and inhibits histone H3 Lys18 acetylation. Genes & Cancer. 6: 30-7. PMID 25821559 DOI: 10.18632/Genesandcancer.47  0.103
2018 Greenberg JM, Wynn JK, Lee J, Hellemann G, Gabrielian S, Green MF. Resilience in homeless veterans: Clinical and cognitive correlates. Psychiatric Rehabilitation Journal. PMID 30489141 DOI: 10.1037/Prj0000333  0.103
2012 Xie L, Gazin C, Park SM, Zhu LJ, Debily MA, Kittler EL, Zapp ML, Lapointe D, Gobeil S, Virbasius CM, Green MR. A synthetic interaction screen identifies factors selectively required for proliferation and TERT transcription in p53-deficient human cancer cells. Plos Genetics. 8: e1003151. PMID 23284306 DOI: 10.1371/Journal.Pgen.1003151  0.103
2023 Preiksaitis J, Allen U, Bollard CM, Dharnidharka VR, Dulek DE, Green M, Martinez OM, Metes DM, Michaels MG, Smets F, Chinnock RE, Comoli P, Danziger-Isakov L, Dipchand AI, Esquivel CO, et al. The IPTA Nashville Consensus Conference on Post-Transplant lymphoproliferative disorders after solid organ transplantation in children: III - Consensus guidelines for Epstein-Barr virus load and other biomarker monitoring. Pediatric Transplantation. e14471. PMID 37294621 DOI: 10.1111/petr.14471  0.103
1990 Green MF, Ganzell S, Satz P, Vaclav JF. Teaching the Wisconsin Card Sorting Test to schizophrenic patients. Archives of General Psychiatry. 47: 91-2. PMID 2294860 DOI: 10.1001/Archpsyc.1990.01810130093016  0.103
2021 Fiskus W, Mill CP, Nabet B, Perera D, Birdwell C, Manshouri T, Lara B, Kadia TM, DiNardo C, Takahashi K, Daver N, Bose P, Masarova L, Pemmaraju N, Kornblau S, ... ... Green MR, et al. Superior efficacy of co-targeting GFI1/KDM1A and BRD4 against AML and post-MPN secondary AML cells. Blood Cancer Journal. 11: 98. PMID 34016956 DOI: 10.1038/s41408-021-00487-3  0.102
2023 Steiner RE, Parra ER, Vega F, Feng L, Westin JR, Neelapu SS, Strati P, Green MR, Flowers CR, Solis LM, Wistuba II, Ahmed S, Nair R, Hagemeister FB, Noorani M, et al. PD-L1 macrophages are associated with favorable features in primary mediastinal (thymic) large B-cell lymphoma. Experimental Hematology & Oncology. 12: 32. PMID 36941707 DOI: 10.1186/s40164-023-00396-0  0.102
2015 Davoren JE, O'Neil SV, Anderson DP, Brodney MA, Chenard L, Dlugolenski K, Edgerton JR, Green M, Garnsey M, Grimwood S, Harris AR, Kauffman GW, LaChapelle E, Lazzaro JT, Lee CW, et al. Design and optimization of selective azaindole amide M1 positive allosteric modulators. Bioorganic & Medicinal Chemistry Letters. PMID 26631313 DOI: 10.1016/J.Bmcl.2015.11.053  0.102
2015 Green ML, Herzing DL, Baldwin JD. Molecular assessment of mating strategies in a population of Atlantic spotted dolphins. Plos One. 10: e0118227. PMID 25692972 DOI: 10.1371/Journal.Pone.0118227  0.102
2013 Aya-Bonilla C, Green MR, Camilleri E, Benton M, Keane C, Marlton P, Lea R, Gandhi MK, Griffiths LR. High-resolution loss of heterozygosity screening implicates PTPRJ as a potential tumor suppressor gene that affects susceptibility to Non-Hodgkin's lymphoma. Genes, Chromosomes & Cancer. 52: 467-79. PMID 23341091 DOI: 10.1002/Gcc.22044  0.102
2015 Smith CS, Gerrish WG, Nash M, Fisher A, Brotman A, Smith D, Student A, Green M, Donovan J, Dreffin M. Professional equipoise: Getting beyond dominant discourses in an interprofessional team. Journal of Interprofessional Care. 29: 603-609. PMID 26652633 DOI: 10.3109/13561820.2015.1051216  0.102
2021 Fiskus W, Mill CP, Perera D, Birdwell C, Deng Q, Yang H, Lara BH, Jain N, Burger J, Ferrajoli A, Davis JA, Saenz DT, Jin W, Coarfa C, Crews CM, ... Green MR, et al. BET proteolysis targeted chimera-based therapy of novel models of Richter Transformation-diffuse large B-cell lymphoma. Leukemia. PMID 33654205 DOI: 10.1038/s41375-021-01181-w  0.101
2006 Lee SH, Wynn JK, Green MF, Kim H, Lee KJ, Nam M, Park JK, Chung YC. Quantitative EEG and low resolution electromagnetic tomography (LORETA) imaging of patients with persistent auditory hallucinations. Schizophrenia Research. 83: 111-9. PMID 16524699 DOI: 10.1016/J.Schres.2005.11.025  0.1
2016 Crabtree J, Green MJ. Creative Cognition and Psychosis Vulnerability: What’s the Difference? Creativity Research Journal. 28: 24-32. DOI: 10.1080/10400419.2015.1030305  0.1
1998 Kee KS, Kern RS, Green MF. Perception of emotion and neurocognitive functioning in schizophrenia: what's the link? Psychiatry Research. 81: 57-65. PMID 9829651 DOI: 10.1016/S0165-1781(98)00083-3  0.1
2015 Horan WP, Reise SP, Kern RS, Lee J, Penn DL, Green MF. Structure and correlates of self-reported empathy in schizophrenia. Journal of Psychiatric Research. 66: 60-6. PMID 25985922 DOI: 10.1016/J.Jpsychires.2015.04.016  0.1
2015 Green MA, Subramanian SV, Vickers D, Dorling D. Internal migration, area effects and health: Does where you move to impact upon your health? Social Science & Medicine (1982). 136: 27-34. PMID 25978650 DOI: 10.1016/j.socscimed.2015.05.011  0.099
2020 Yang H, Green MR. Harnessing lymphoma epigenetics to improve therapies. Blood. PMID 33206943 DOI: 10.1182/blood.2020006908  0.099
2017 Jimenez AM, Lee J, Wynn JK, Green MF. The neural correlates of self-referential memory encoding and retrieval in schizophrenia. Neuropsychologia. PMID 29217224 DOI: 10.1016/J.Neuropsychologia.2017.12.004  0.099
2015 Turetsky BI, Dress EM, Braff DL, Calkins ME, Green MF, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Nuechterlein KH, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Sprock J, et al. The utility of P300 as a schizophrenia endophenotype and predictive biomarker: clinical and socio-demographic modulators in COGS-2. Schizophrenia Research. 163: 53-62. PMID 25306203 DOI: 10.1016/J.Schres.2014.09.024  0.099
2020 Yang H, Green MR. Harnessing lymphoma epigenetics to improve therapies (article not eligible for CME credit). Hematology. American Society of Hematology. Education Program. 2020: 95-100. PMID 33385237 DOI: 10.1182/hematology.2020006908  0.099
2020 Yang H, Green MR. Harnessing lymphoma epigenetics to improve therapies (article not eligible for CME credit). Hematology. American Society of Hematology. Education Program. 2020: 95-100. PMID 33327001 DOI: 10.1182/hematology.2020006908  0.099
2003 Green M, Webber S. Posttransplantation lymphoproliferative disorders Pediatric Clinics of North America. 50: 1471-1491. PMID 14710788 DOI: 10.1016/S0031-3955(03)00127-5  0.099
2011 Nguyen-Van D, Keane C, Han E, Jones K, Nourse JP, Vari F, Ross N, Crooks P, Ramuz O, Green M, Griffith L, Trappe R, Grigg A, Mollee P, Gandhi MK. Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly expresses EBNA3A with conserved CD8 T-cell epitopes. American Journal of Blood Research. 1: 146-59. PMID 22432076  0.098
2020 Yang H, Green MR. Harnessing lymphoma epigenetics to improve therapies. Hematology. American Society of Hematology. Education Program. 2020: 95-100. PMID 33275741 DOI: 10.1182/hematology.2020006908  0.098
2024 Yamada M, L'Huillier AG, Green M. A Focused Review of Epstein-Barr Virus Infections and PTLD in Pediatric Transplant Recipients: Guidance From the IPTA and ECIL Guidelines. Journal of the Pediatric Infectious Diseases Society. 13: S31-S38. PMID 38417085 DOI: 10.1093/jpids/piad097  0.098
2024 Huang L, Tuzer F, Murtha A, Green M, Torres C, Liu H, Malaeb S. Differential Susceptibility to Propofol and Ketamine in Primary Cultures of Young and Senesced Astrocytes. Anesthesiology Research and Practice. 2024: 8876548. PMID 38633620 DOI: 10.1155/2024/8876548  0.098
1997 Green MF, Nuechterlein KH. Early visual processing deficits in remitted, unmedicated schizophrenic patients Schizophrenia Research. 24: 105-106. DOI: 10.1016/S0920-9964(97)82291-8  0.097
2009 Renwick W, Pettengell R, Green M. Use of filgrastim and pegfilgrastim to support delivery of chemotherapy: twenty years of clinical experience. Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy. 23: 175-86. PMID 19627169 DOI: 10.2165/00063030-200923030-00004  0.097
2023 Strati P, Jallouk A, Deng Q, Li X, Feng L, Sun R, Adkins S, Johncy S, Cain T, Steiner RE, Ahmed S, Chihara D, Fayad LE, Padmanabhan Iyer S, Horowitz SB, ... ... Green MR, et al. A Phase I Study of Prophylactic Anakinra to Mitigate ICANS in Patients with Large B-cell Lymphoma. Blood Advances. PMID 37389847 DOI: 10.1182/bloodadvances.2023010653  0.097
2010 Green MR, Jardine P, Wood P, Wellwood J, Lea RA, Marlton P, Griffiths LR. A new method to detect loss of heterozygosity using cohort heterozygosity comparisons. Bmc Cancer. 10: 195. PMID 20462409 DOI: 10.1186/1471-2407-10-195  0.097
2015 Randall LV, Green MJ, Chagunda MG, Mason C, Archer SC, Green LE, Huxley JN. Low body condition predisposes cattle to lameness: An 8-year study of one dairy herd. Journal of Dairy Science. 98: 3766-77. PMID 25828666 DOI: 10.3168/jds.2014-8863  0.097
2015 Tabernero P, Mayxay M, Culzoni MJ, Dwivedi P, Swamidoss I, Allan EL, Khanthavong M, Phonlavong C, Vilayhong C, Yeuchaixiong S, Sichanh C, Sengaloundeth S, Kaur H, Fernández FM, Green MD, et al. A Repeat Random Survey of the Prevalence of Falsified and Substandard Antimalarials in the Lao PDR: A Change for the Better. The American Journal of Tropical Medicine and Hygiene. 92: 95-104. PMID 25897062 DOI: 10.4269/Ajtmh.15-0057  0.097
2023 Breton M, Gaboury I, Martin E, Green ME, Kiran T, Laberge M, Kaczorowski J, Ivers N, Deville-Stoetzel N, Bordeleau F, Beaulieu C, Descoteaux S. Impact of externally facilitated continuous quality improvement cohorts on Advanced Access to support primary healthcare teams: protocol for a quasi-randomized cluster trial. Bmc Primary Care. 24: 97. PMID 37038126 DOI: 10.1186/s12875-023-02048-y  0.096
2011 Wajapeyee N, Green MR. Induction of senescence in melanoma: thinking outside the cell. Pigment Cell & Melanoma Research. 24: 874-5. PMID 22081810 DOI: 10.1111/J.1755-148X.2011.00895.X  0.096
2024 Yamada M, Chen SF, Green M. Chronic Epstein-Barr viral load carriage after pediatric organ transplantation. Frontiers in Pediatrics. 12: 1335496. PMID 38357509 DOI: 10.3389/fped.2024.1335496  0.096
2011 Green MR, Aya-Bonilla C, Gandhi MK, Lea RA, Wellwood J, Wood P, Marlton P, Griffiths LR. Integrative genomic profiling reveals conserved genetic mechanisms for tumorigenesis in common entities of non-Hodgkin's lymphoma. Genes, Chromosomes & Cancer. 50: 313-26. PMID 21305641 DOI: 10.1002/Gcc.20856  0.096
2019 Peterson DL, Webb CA, Keeley JW, Gaebel W, Zielasek J, Rebello TJ, Robles R, Matsumoto C, Kogan CS, Kulygina M, Farooq S, Green MF, Falkai P, Hasan A, Galderisi S, et al. The reliability and clinical utility of ICD-11 schizoaffective disorder: A field trial. Schizophrenia Research. PMID 30799218 DOI: 10.1016/J.Schres.2019.02.011  0.096
2021 Mill CP, Fiskus W, DiNardo CD, Birdwell C, Davis JA, Kadia TM, Takahashi K, Short NJ, Daver NG, Ohanian M, Borthakur G, Kornblau SM, Green MR, Qi Y, Su X, et al. Effective therapy of AML with RUNX1 mutation by co-treatment with inhibitors of protein translation and BCL2. Blood. PMID 34601571 DOI: 10.1182/blood.2021013156  0.095
2020 Chaudhuri A, Goddard EA, Green M, Ardura MI. Diarrhea in the pediatric solid organ transplantation recipient: A multidisciplinary approach to diagnosis and management. Pediatric Transplantation. e13886. PMID 33142366 DOI: 10.1111/petr.13886  0.095
2011 Green MR, Monti S, Dalla-Favera R, Pasqualucci L, Walsh NC, Schmidt-Supprian M, Kutok JL, Rodig SJ, Neuberg DS, Rajewsky K, Golub TR, Alt FW, Shipp MA, Manis JP. Signatures of murine B-cell development implicate Yy1 as a regulator of the germinal center-specific program. Proceedings of the National Academy of Sciences of the United States of America. 108: 2873-8. PMID 21282644 DOI: 10.1073/Pnas.1019537108  0.095
2010 Wajapeyee N, Wang SZ, Serra RW, Solomon PD, Nagarajan A, Zhu X, Green MR. Senescence induction in human fibroblasts and hematopoietic progenitors by leukemogenic fusion proteins. Blood. 115: 5057-60. PMID 20421454 DOI: 10.1182/Blood-2009-09-245928  0.095
2008 Tran H, Nourse J, Hall S, Green M, Griffiths L, Gandhi MK. Immunodeficiency-associated lymphomas Blood Reviews. 22: 261-281. PMID 18456377 DOI: 10.1016/J.Blre.2008.03.009  0.095
2022 Cherng HJ, Alig S, Oki Y, Nastoupil LJ, Fayad LE, Neelapu SS, Turturro F, Hagemeister FB, Craig A, Macaulay C, Rodriguez MA, Lee HJJ, McDonnell T, Flowers CR, Vega F, ... Green MR, et al. A phase 1/2 study of lenalidomide and obinutuzumab with CHOP for newly diagnosed DLBCL. Blood Advances. PMID 36375046 DOI: 10.1182/bloodadvances.2022008174  0.094
2015 Schwartz N, Nachum Z, Green MS. The prevalence of gestational diabetes mellitus recurrence-effect of ethnicity and parity: a metaanalysis. American Journal of Obstetrics and Gynecology. PMID 25757637 DOI: 10.1016/j.ajog.2015.03.011  0.094
2021 Strati P, Ahmed S, Furqan F, Fayad LE, Lee HJ, Iyer SP, Nair R, Nastoupil L, Parmar S, Rodriguez MA, Samaniego F, Steiner RE, Wang ML, Pinnix CC, Horowitz SB, ... ... Green MR, et al. Prognostic Impact of Corticosteroids on Efficacy of Chimeric Antigen Receptor T-cell Therapy in Large B-cell Lymphoma. Blood. PMID 33534891 DOI: 10.1182/blood.2020008865  0.094
2022 Wang F, Calvo-Roitberg E, Rembetsy-Brown JM, Fang M, Sousa J, Kartje ZJ, Krishnamurthy PM, Lee J, Green MR, Pai AA, Watts JK. G-rich motifs within phosphorothioate-based antisense oligonucleotides (ASOs) drive activation of FXN expression through indirect effects. Nucleic Acids Research. PMID 36511872 DOI: 10.1093/nar/gkac1108  0.094
2023 Catalano LT, Green MF. Approaches to Studying and Improving Social Motivation in Schizophrenia. Schizophrenia Bulletin. PMID 37410026 DOI: 10.1093/schbul/sbad101  0.094
2013 Yang ZF, Zhang H, Ma L, Peng C, Chen Y, Wang J, Green MR, Li S, Rosmarin AG. GABP transcription factor is required for development of chronic myelogenous leukemia via its control of PRKD2. Proceedings of the National Academy of Sciences of the United States of America. 110: 2312-7. PMID 23345428 DOI: 10.1073/Pnas.1212904110  0.093
2010 Sheng Z, Li L, Zhu LJ, Smith TW, Demers A, Ross AH, Moser RP, Green MR. A genome-wide RNA interference screen reveals an essential CREB3L2-ATF5-MCL1 survival pathway in malignant glioma with therapeutic implications. Nature Medicine. 16: 671-7. PMID 20495567 DOI: 10.1038/Nm.2158  0.093
2022 Nastoupil LJ, Chin CK, Westin JR, Fowler NH, Samaniego F, Cheng X, Ma MCJ, Wang Z, Chu F, Dsouza L, Obi C, Mims JT, Feng L, Zhou S, Green MR, et al. Safety and activity of pembrolizumab in combination with rituximab in relapsed or refractory follicular lymphoma. Blood Advances. PMID 35015819 DOI: 10.1182/bloodadvances.2021006240  0.093
2021 Breton M, Smithman MA, Kreindler SA, Jbilou J, Wong ST, Gard Marshall E, Sasseville M, Sutherland JM, Crooks VA, Shaw J, Contandriopoulos D, Brousselle A, Green M. Designing centralized waiting lists for attachment to a primary care provider: Considerations from a logic analysis. Evaluation and Program Planning. 101962. PMID 34127272 DOI: 10.1016/j.evalprogplan.2021.101962  0.093
2010 Kasiske BL, Zeier MG, Chapman JR, Craig JC, Ekberg H, Garvey CA, Green MD, Jha V, Josephson MA, Kiberd BA, Kreis HA, McDonald RA, Newmann JM, Obrador GT, Vincenti FG, et al. KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary. Kidney International. 77: 299-311. PMID 19847156 DOI: 10.1038/ki.2009.377  0.092
2015 Seidman LJ, Hellemann G, Nuechterlein KH, Greenwood TA, Braff DL, Cadenhead KS, Calkins ME, Freedman R, Gur RE, Gur RC, Lazzeroni LC, Light GA, Olincy A, Radant AD, Siever LJ, ... ... Green MF, et al. Factor structure and heritability of endophenotypes in schizophrenia: findings from the Consortium on the Genetics of Schizophrenia (COGS-1). Schizophrenia Research. 163: 73-9. PMID 25682549 DOI: 10.1016/J.Schres.2015.01.027  0.092
2020 Parsa S, Ortega-Molina A, Ying HY, Jiang M, Teater M, Wang J, Zhao C, Reznik E, Pasion JP, Kuo D, Mohan P, Wang S, Camarillo JM, Thomas PM, Jain N, ... Green MR, et al. The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencing. Nature Cancer. 1: 653-664. PMID 33569544 DOI: 10.1038/s43018-020-0080-0  0.092
2014 Green MR, Vicente-Dueñas C, Romero-Camarero I, Long Liu C, Dai B, González-Herrero I, García-Ramírez I, Alonso-Escudero E, Iqbal J, Chan WC, Campos-Sanchez E, Orfao A, Pintado B, Flores T, Blanco O, et al. Transient expression of Bcl6 is sufficient for oncogenic function and induction of mature B-cell lymphoma. Nature Communications. 5: 3904. PMID 24887457 DOI: 10.1038/Ncomms4904  0.092
2017 Breton M, Green M, Kreindler S, Sutherland J, Jbilou J, Wong ST, Shaw J, Crooks VA, Contandriopoulos D, Smithman MA, Brousselle A. A comparative analysis of centralized waiting lists for patients without a primary care provider implemented in six Canadian provinces: study protocol. Bmc Health Services Research. 17: 60. PMID 28109279 DOI: 10.1186/S12913-017-2007-8  0.092
2019 Chinchilla M, Gabrielian S, Hellemann G, Glasmeier A, Green M. Determinants of Community Integration Among Formerly Homeless Veterans Who Received Supportive Housing. Frontiers in Psychiatry. 10: 472. PMID 31297070 DOI: 10.3389/Fpsyt.2019.00472  0.092
2006 Shaneyfelt T, Baum KD, Bell D, Feldstein D, Houston TK, Kaatz S, Whelan C, Green M. Instruments for evaluating education in evidence-based practice: A systematic review Journal of the American Medical Association. 296: 1116-1127. PMID 16954491 DOI: 10.1001/jama.296.9.1116  0.092
2023 Sarott R, Gourisankar S, Karim B, Nettles S, Yang H, Dwyer BG, Simanauskaite JM, Tse J, Abuzaid H, Krokhotin A, Zhang T, Hinshaw SM, Green MR, Crabtree GR, Gray NS. Borrowing Transcriptional Kinases to Activate Apoptosis. Biorxiv : the Preprint Server For Biology. PMID 37961702 DOI: 10.1101/2023.10.23.563687  0.092
2009 Green MR, Gandhi MK, Courtney MJ, Marlton P, Griffiths L. Relative abundance of full-length and truncated FOXP1 isoforms is associated with differential NFkappaB activity in Follicular Lymphoma. Leukemia Research. 33: 1699-702. PMID 19487025 DOI: 10.1016/J.Leukres.2009.05.004  0.091
2022 Horan WP, Catalano LT, Green MF. An Update on Treatment of Cognitive Impairment Associated with Schizophrenia. Current Topics in Behavioral Neurosciences. PMID 35915386 DOI: 10.1007/7854_2022_382  0.091
2015 Wynn JK, Roach BJ, Lee J, Horan WP, Ford JM, Jimenez AM, Green MF. EEG findings of reduced neural synchronization during visual integration in schizophrenia. Plos One. 10: e0119849. PMID 25785939 DOI: 10.1371/Journal.Pone.0119849  0.091
2023 Yang J, Chen Y, Jing Y, Green MR, Han L. Advancing CAR T cell therapy through the use of multidimensional omics data. Nature Reviews. Clinical Oncology. PMID 36721024 DOI: 10.1038/s41571-023-00729-2  0.091
2015 Bradley AJ, De Vliegher S, Green MJ, Larrosa P, Payne B, van de Leemput ES, Samson O, Valckenier D, Van Werven T, Waldeck HW, White V, Goby L. An investigation of the dynamics of intramammary infections acquired during the dry period on European dairy farms. Journal of Dairy Science. PMID 26117352 DOI: 10.3168/jds.2014-8749  0.09
2004 Artenstein AW, Opal SM, Cristofaro P, Palardy JE, Parejo NA, Green MD, Jhung JW. Chloroquine enhances survival in Bacillus anthracis intoxication. The Journal of Infectious Diseases. 190: 1655-60. PMID 15478072 DOI: 10.1086/424853  0.09
2023 Desai PN, Wang B, Fonseca A, Borges P, Jelloul FZ, Reville PK, Lee E, Ly C, Basi A, Root J, Baran N, Post SM, Deng Q, Sun H, Harmanci AO, ... ... Green MR, et al. Single-Cell Profiling of CD8+ T Cells in Acute Myeloid Leukemia Reveals a Continuous Spectrum of Differentiation and Clonal Hyperexpansion. Cancer Immunology Research. OF1-OF18. PMID 37285177 DOI: 10.1158/2326-6066.CIR-22-0961  0.09
2009 Kleinman L, Lieberman J, Dube S, Mohs R, Zhao Y, Kinon B, Carpenter W, Harvey PD, Green MF, Keefe RS, Frank L, Bowman L, Revicki DA. Development and psychometric performance of the schizophrenia objective functioning instrument: an interviewer administered measure of function. Schizophrenia Research. 107: 275-85. PMID 19013769 DOI: 10.1016/J.Schres.2008.10.002  0.09
2023 Premji K, Green ME, Glazier RH, Khan S, Schultz SE, Mathews M, Nastos S, Frymire E, Ryan BL. Characteristics of patients attached to near-retirement family physicians: a population-based serial cross-sectional study in Ontario, Canada. Bmj Open. 13: e074120. PMID 38149429 DOI: 10.1136/bmjopen-2023-074120  0.09
2021 Szydłowski M, Garbicz F, Jabłońska E, Górniak P, Komar D, Pyrzyńska B, Bojarczuk K, Prochorec-Sobieszek M, Szumera-Ciećkiewicz A, Rymkiewicz G, Cybulska M, Statkiewicz M, Gajewska M, Mikula M, Gołas A, ... ... Green MR, et al. Inhibition of PIM Kinases in DLBCL Targets MYC Transcriptional Program and Augments the Efficacy of Anti-CD20 Antibodies. Cancer Research. PMID 34625423 DOI: 10.1158/0008-5472.CAN-21-1023  0.09
2019 Alcamo AM, Wolf MS, Alessi LJ, Chong HJ, Green M, Williams JV, Simon DW. Successful Use of Cidofovir in an Immunocompetent Child With Severe Adenoviral Sepsis. Pediatrics. PMID 31826930 DOI: 10.1542/Peds.2019-1632  0.089
2010 Lau AH, Soltys K, Sindhi RK, Bond G, Mazariegos GV, Green M. Chronic high Epstein-Barr viral load carriage in pediatric small bowel transplant recipients. Pediatric Transplantation. 14: 549-53. PMID 20102529 DOI: 10.1111/j.1399-3046.2009.01283.x  0.089
2011 Wan S, Wu F, Rech JC, Green ME, Balachandran R, Horne WS, Day BW, Floreancig PE. Total synthesis and biological evaluation of pederin, psymberin, and highly potent analogs. Journal of the American Chemical Society. 133: 16668-79. PMID 21902245 DOI: 10.1021/Ja207331M  0.089
2015 Leach KA, Archer SC, Breen JE, Green MJ, Ohnstad IC, Tuer S, Bradley AJ. Recycling manure as cow bedding: Potential benefits and risks for UK dairy farms. Veterinary Journal (London, England : 1997). 206: 123-30. PMID 26388545 DOI: 10.1016/j.tvjl.2015.08.013  0.089
2009 Kalechstein AD, De la Garza R, Newton TF, Green MF, Cook IA, Leuchter AF. Quantitative EEG abnormalities are associated with memory impairment in recently abstinent methamphetamine-dependent individuals. The Journal of Neuropsychiatry and Clinical Neurosciences. 21: 254-8. PMID 19776303 DOI: 10.1176/JNP.2009.21.3.254  0.089
2014 Sheng Z, Murphy SF, Guo S, Green MR. A diphtheria toxin negative selection in RNA interference screening. Methods in Molecular Biology (Clifton, N.J.). 1176: 59-72. PMID 25030919 DOI: 10.1007/978-1-4939-0992-6_6  0.089
2014 Schubart JR, Levi BH, Dellasega C, Whitehead M, Green MJ. Factors that affect decisions to receive (or not receive) life-sustaining treatment in advance care planning. Journal of Psychosocial Nursing and Mental Health Services. 52: 38-44. PMID 24200911 DOI: 10.3928/02793695-20131028-01  0.089
2021 Alcamo AM, Trivedi MK, Dulabon C, Horvat CM, Bond GJ, Carcillo JA, Green M, Michaels MG, Aneja RK. Multidrug-Resistant Organisms: A Significant Cause of Severe Sepsis in Pediatric Intestinal and Multi-visceral Transplantation. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. PMID 34245113 DOI: 10.1111/ajt.16756  0.089
2021 Bugide S, Gupta R, Green MR, Wajapeyee N. EZH2 inhibits NK cell-mediated antitumor immunity by suppressing CXCL10 expression in an HDAC10-dependent manner. Proceedings of the National Academy of Sciences of the United States of America. 118. PMID 34301901 DOI: 10.1073/pnas.2102718118  0.089
2017 Khodadoust MS, Olsson N, Wagar LE, Haabeth OA, Chen B, Swaminathan K, Rawson K, Liu CL, Steiner D, Lund P, Rao S, Zhang L, Marceau C, Stehr H, Newman AM, ... ... Green MR, et al. Antigen presentation profiling reveals recognition of lymphoma immunoglobulin neoantigens. Nature. PMID 28329770 DOI: 10.1038/Nature21433  0.089
2020 Gallagher KM, Roderick JE, Tan SH, Tan TK, Murphy L, Yu J, Li R, O'Connor KW, Zhu J, Green MR, Sanda T, Kelliher MA. ESRRB regulates glucocorticoid gene expression in mice and patients with acute lymphoblastic leukemia. Blood Advances. 4: 3154-3168. PMID 32658986 DOI: 10.1182/Bloodadvances.2020001555  0.089
2021 Elgarten CW, Tanes C, Lee JJ, Danziger-Isakov LA, Grimley MS, Green M, Michaels MG, Barnum JL, Ardura MI, Auletta JJ, Blumenstock J, Seif AE, Bittinger KL, Fisher BT. Early stool microbiome and metabolome signatures in pediatric patients undergoing allogeneic hematopoietic cell transplantation. Pediatric Blood & Cancer. e29384. PMID 34709713 DOI: 10.1002/pbc.29384  0.089
2015 Green MF, Llerena K, Kern RS. The "Right Stuff" Revisited: What Have We Learned About the Determinants of Daily Functioning in Schizophrenia? Schizophrenia Bulletin. 41: 781-5. PMID 25750248 DOI: 10.1093/Schbul/Sbv018  0.089
2022 Bell HN, Huber AK, Singhal R, Korimerla N, Rebernick RJ, Kumar R, El-Derany MO, Sajjakulnukit P, Das NK, Kerk SA, Solanki S, James JG, Kim D, Zhang L, Chen B, ... ... Green M, et al. Microenvironmental ammonia enhances T cell exhaustion in colorectal cancer. Cell Metabolism. PMID 36528023 DOI: 10.1016/j.cmet.2022.11.013  0.089
2015 Hernandez-Meza G, Izzetoglu M, Osbakken M, Green M, Izzetoglu K. Near-Infrared Spectroscopy for the Evaluation of Anesthetic Depth. Biomed Research International. 2015: 939418. PMID 26495317 DOI: 10.1155/2015/939418  0.088
2018 Wong ST, Langton JM, Katz A, Fortin M, Godwin M, Green M, Grunfeld E, Hassani K, Kendall C, Liddy C, Ploeg J, Wodchis WP, Haggerty JL. Promoting cross-jurisdictional primary health care research: developing a set of common indicators across 12 community-based primary health care teams in Canada. Primary Health Care Research & Development. 1-7. PMID 30396376 DOI: 10.1017/S1463423618000518  0.088
2021 Poulter JA, Collins JC, Cargo C, de Tute RM, Evans P, Ospina Cardona D, Bowen DT, Cunnington JR, Baguley E, Quinn M, Green M, McGonagle D, Beck DB, Werner A, Savic S. Novel somatic mutations in UBA1 as a cause of VEXAS syndrome. Blood. PMID 33690815 DOI: 10.1182/blood.2020010286  0.088
2004 Wallis CV, Sheerin AN, Green MH, Jones CJ, Kipling D, Faragher RG. Fibroblast clones from patients with Hutchinson-Gilford progeria can senesce despite the presence of telomerase. Experimental Gerontology. 39: 461-7. PMID 15050279 DOI: 10.1016/j.exger.2003.12.015  0.088
2015 Block KI, Gyllenhaal C, Lowe L, Amedei A, Amin AR, Amin A, Aquilano K, Arbiser J, Arreola A, Arzumanyan A, Ashraf SS, Azmi AS, Benencia F, Bhakta D, Bilsland A, ... ... Green MF, et al. Designing a broad-spectrum integrative approach for cancer prevention and treatment. Seminars in Cancer Biology. 35: S276-304. PMID 26590477 DOI: 10.1016/J.Semcancer.2015.09.007  0.088
1991 Bowman JS, Green M, Scantlebury VP, Todo S, Tzakis A, Iwatsuki S, Douglas L, Starzl TE. OKT3 and viral disease in pediatric liver transplant recipients. Clinical Transplantation. 5: 294-300. PMID 21170278  0.088
2007 Teodoro JG, Evans SK, Green MR. Inhibition of tumor angiogenesis by p53: a new role for the guardian of the genome. Journal of Molecular Medicine (Berlin, Germany). 85: 1175-86. PMID 17589818 DOI: 10.1007/S00109-007-0221-2  0.088
2015 Light GA, Swerdlow NR, Thomas ML, Calkins ME, Green MF, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Nuechterlein KH, Pela M, Radant AD, Seidman LJ, Sharp RF, Siever LJ, et al. Validation of mismatch negativity and P3a for use in multi-site studies of schizophrenia: characterization of demographic, clinical, cognitive, and functional correlates in COGS-2. Schizophrenia Research. 163: 63-72. PMID 25449710 DOI: 10.1016/J.Schres.2014.09.042  0.088
2023 Brown B, Ojha V, Fricke I, Al-Sheboul SA, Imarogbe C, Gravier T, Green M, Peterson L, Koutsaroff IP, Demir A, Andrieu J, Leow CY, Leow CH. Innate and Adaptive Immunity during SARS-CoV-2 Infection: Biomolecular Cellular Markers and Mechanisms. Vaccines. 11. PMID 36851285 DOI: 10.3390/vaccines11020408  0.088
2002 Basser RL, O'Flaherty E, Green M, Edmonds M, Nichol J, Menchaca DM, Cohen B, Begley CG. Development of pancytopenia with neutralizing antibodies to thrombopoietin after multicycle chemotherapy supported by megakaryocyte growth and development factor. Blood. 99: 2599-602. PMID 11895799 DOI: 10.1182/Blood.V99.7.2599  0.087
2022 Tobin JWD, Green MR, Gandhi MK. The PO4-tential for Less Toxic CAR T-cell Therapies. Cancer Immunology Research. OF1. PMID 36327248 DOI: 10.1158/2326-6066.CIR-22-0793  0.087
2017 Greenberg J, Wynn JK, Lee J, Hellemann G, Green MF. 95. Resilience in Homeless Veterans With and Without a History of Psychosis Schizophrenia Bulletin. 43: S51-S51. DOI: 10.1093/Schbul/Sbx021.134  0.087
Hide low-probability matches.